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This thesis explores the application of economic evaluation to public health interventions. The motivation for 
the thesis was experience gained through a number of applied research programmes on which the author was 
the lead investigator or co-lead investigator.  The experience gained over the course of these programmes 
highlighted that cost utility analysis has significant shortcomings when applied to public health interventions.  
Many of these shortcomings stem from fundamental uncertainties around the attributable effect of the public 
health interventions which is more difficult to estimate in tightly controlled studies than other healthcare 
interventions, such as pharmaceuticals.  In addition, where data are available they typically report easily-
measured, short-term, behaviour change such as an increase in physical activity, rather than the resulting long-
term health outcome, such as a reduction in cardiovascular disease. By adopting long-term (even lifetime) 
time horizons in economic models, health economists are often required to make heroic assumptions about 
the longevity and reproducibility of the short-term effects observed in studies and their relationship with 
health outcomes.   
There are also concerns with cost utility analysis that go beyond the data inputs to the core principles of the 
philosophical approach that underlies this method. The foundation of cost utility analysis is extra-welfarism, 
which assumes that population health is the maximand in policy decisions and that presenting outcomes in a 
cost per quality adjusted life year (QALY) format is accessible to all relevant decision makers. In many cases, 
public health interventions have impacts beyond health outcomes and the decision makers for determining 
whether an intervention should be made available may include non-healthcare stakeholders. Environmental 
interventions to promote physical activity included in this thesis are a good example of this. Investment to 
support this intervention is unlikely to be sourced entirely from healthcare budgets, so it is important that 
evalutions of such programmes adopt an appropriate perspective and report outcomes in an accessible format 
for all decision makers.  
A final concern about the application of cost utility analysis is the requirement to aggregate costs and 
outcomes into a composite ratio, typically the incremental cost per QALY. Whilst this provides a common 
denominator for decision making purposes allowing interventions to be directly compared, the use of a ratio 
can mask the magnitude of absolute changes in outcomes. Rather than rely on a composite ratio, decision 
makers would be advised to consider the absolute changes in outcomes, whether these are clinically 
meaningful and the degree of uncertainty around them.  
The over-arching objective of this thesis is to critically assess the commonly applied methods of economic 
evaluation to public health interventions, with a particular focus on cost utility analysis. Rather than undertake 
a methodological critique, the thesis considers a series of applied economic evaluations conducted by the 
author, the lessons learned throughout these and the methodological preferences that resulted. These applied 
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studies provided the impetus to explore alternative approaches to economic evaluation, including the 
application of cost benefit analysis in the evaluation of environmental interventions to promote physical 
activity and interventions to promote breastfeeding. However, like cost utility analysis, the outcomes of cost 
benefit analyses aggregate costs and outcomes into a composite ratio (the cost benefit ratio) which may 
continue to mask uncertainty around the absolute changes in outcomes. By necessity, cost benefit analysis 
also excludes any outcomes which can’t be quantified in monetary terms.   
In light of this, cost consequence analysis was applied to subsequent economic evaluations as a means of 
addressing some of the shortcomings presented above. By presenting outcomes in a disaggregated format, 
decision makers from multiple sectors can determine how they would benefit from an intervention and the 
degree to which they may want to contribute to funding. Reporting outcomes in this way also eliminates the 
need to utilise a narrow health perspective, as in cost utility analysis, or to quantify all outcomes in monetary 
units as in cost benefit analysis.     
On the basis of the applied research presented in this thesis, the author suggests that cost consequence 
analysis should be the preferred method of economic evaluation for public health interventions, particularly 
those that have inter-sectoral costs and effects. The thesis concludes with some reflections on alternative 
methods of economic evaluation and the final chapter includes a simple framework to guide the choice of 
economic evaluation methods. These are intended to inform future evaluatuions of public health 
interventions to ensure that they adopt pragmatic methods and present outcomes in an accessible format for 
decision makers. By doing so, researchers can increase the influence of health economics on public health 







Chapter 1: Introduction  
  
The World Health Organisation suggests that the major determinants of health care relate to the social and 
economic environment, the physical environment and the person’s individual characteristics and behaviours 
(World Health Organisation 2020). These are all variables that might be influenced through public health 
interventions, rather than the provision of health services per se. Whilst there is a universal trend towards 
allocating a greater proportion of government funding to healthcare (World Health Organisation 2019) most 
Western governments continue to allocate the majority of their health service budget to the delivery of care 
and health policy is overwhelmingly focussed on the organisation of health systems and care provision.  
Although international comparisons of public health funding are hindered by differences in sources of funding 
and agencies involved, data from the United States estimates that less than 5% of total healthcare spending is 
allocated to public health (Mays & Smith 2009). This trend is also reflected in the United Kingdom where 
successive governments have made commitments relating to the importance of public health in promoting 
healthy behaviours and the prevention of ill-health (Wanless 2004)(Marmot 2020). In spite of this, the 
proportion of healthcare expenditure allocated to public health has decreased in real terms over the last 
decade (Kings Fund 2018).   
Investment in public health programmes is often more challenging to justify than investment in the provision 
of treatment for ill-health (Richardson 2012). The costs and benefits of public health investments may accrue 
across multiple sectors, including health, social care and local authorities which can create difficulties in 
securing funding. Furthermore, there may be difficulties in attributing an effect to a public health intervention, 
particularly where these are intended to promote population level behaviours or the environment, due to 
confounding factors, such as changes in demographics or health behaviours over time.    
From an economic perspective, the decision to prioritise investment in health care provision and limit funding 
for health promotion to address the determinants of health might be considered a gross inefficiency if health 
promotion can result in a greater return on investment than treatment. However, the extent of any 
inefficiency in resource allocations can only be established through more widespread application of economic 
evaluation to public health programmes to better understand their costs and benefits. The relative dearth of 
high quality and accessible economic evaluations of public health programmes relative to health interventions 
may partly explain these investment decisions.   
 
This thesis will explore some of the challenges associated with conducting economic evaluations of public 
health programmes with the intent of recommending best practices that may increase the influence of 
economic evidence to decision makers. The author’s experience of applying alternative approaches to the 
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economic evaluation of public health programmes will form the basis of the thesis and the subsequent 
recommendations.    
1.1 Aims of the thesis  
The aim of this thesis is to conduct a critical assessment of the application of commonly used methods of 
economic evaluation to public health interventions and develop recommendations for future evaluations. The 
thesis will consider the applicability of the most widely used methods of economic evaluation in healthcare, 
including cost-utility analysis (CUA), cost-effectiveness analysis (CEA) and cost-consequence analysis (CCA). A 
critical assessment of each method will be conducted considering not only the methodological strengths and 
weaknesses of the respective methods but also, and more importantly, their accessibility to decision makers. 
This thesis will comprise a critique of 9 published research studies conducted by the author which reports a 
series of applied economic evaluations of public health interventions. The author has an extensive publication 
list of applied economic evaluations. The studies selected for inclusion in this thesis were selected on the basis 
that they illustrate continued learning and refinement of methodologies applied to the evaluation of public 
health interventions over time. One additional study from 1999 is included as context (Duthie et al 1999).  This 
study examined the use of health economics by health service decision makers and helped shape the authors 
attitude to economic evaluation over the course of their career. The study emphasises the need to ensure 
health economic methods reflect the needs of decision makers and that results are presented in an accessible 
fashion. Many of the insights from this study helped to inform the authors future research, including the 
studies herein.    
In each case, the author has made a significant contribution to the design and execution of the study or has 
directly led the research and resulting publication. In some instances, lead authorship was granted to junior 
researchers who were considered to be the main contributor to a particular aspect of a study programme (e.g. 
the systematic review or model development) under the oversight of the author. The table below summarises 
the author’s contribution to each study.   





Table 1.1. Author’s contribution to publications included in the thesis. 
 





3 Publication #1  
 
Duthie T, Trueman P, Chancellor J, 
Diez L. Research into the use of 
health economics in decision making 
in the United Kingdom--Phase II. Is 
health economics 'for good or evil'? 





Study design, interview 
guide, annotating 
responses, thematic 
analysis of responses 
and manuscript 
development.   
121  Widely cited, including in the 
development of methodological 
guidelines from the International 
Society for Pharmacoeconomics and 
Outcomes Research (ISPOR), early 
commentary on NICE methods and 
more recent discussion of the role of 





Publication #2  
 
Trueman P, Haynes SM, Felicity Lyons 
G, Louise McCombie E, McQuigg MS, 
Mongia S, Noble PA, Quinn MF, Ross 
HM, Thompson F, Broom JI, Laws RA, 
Reckless JP, Kumar S, Lean ME, Frost 
GS, Finer N, Haslam DW, Morrison D, 
Sloan B; Counterweight Project Team. 
Long-term cost-effectiveness of 
weight management in primary care. 





Led study design, model 
development, 
interpretation and 
manuscript development  
68 One of the first examples of a cost 
effectiveness analysis of weight loss 
interventions based on high quality, 





Publication #3  
 
McQuigg M, Broom JI, Laws R, 
Reckless J, Noble P, Kumar S, 
McCombie L, Lean M, Lyons F, 
Mongia S, Frost G, Quinn M, Barth JH, 
Haynes S, Finer N, Haslam DW, Ross 
H, Hole D, Radziwonik S, Sloan B, 








development.   
13 Input to the decision to fund the 
Counterweight programme across 
Scotland by illustrating that the cost 
of prescribing the intervention can 
be partly offset by reductions in 





body mass index on prescribing costs 
and potential cost savings of a weight 
management programme in primary 
care. J Health Serv Res Policy 2008; 






Beale SJ, Bending MW, Trueman P, 
Naidoo B. Should we invest in 
environmental interventions to 
encourage physical activity in 
England? An economic appraisal. 
European Journal of Public Health 




Led overall research 
programme, defined 
model structure and 
parameters, 
interpretation of results 
and manuscript 
development.   
26 Direct input to NICE guideline on 
environmental interventions to 
promote physical activity.  The first 
major deviation from the NICE 
reference case (cost utility analysis) 
in the evaluation of public health 
interventions which has influenced 
subsequent methods guidance.  
Cited by research conducted in 







6 Publication #5 
  
Pokhrel S, Quigley MA, Fox-Rushby J, 
McCormick F, Williams A, Trueman P, 
Dodds R, Renfrew MJ. Potential 
economic impacts from improving 
breastfeeding rates in the UK. Arch 





Co-lead investigator of 
research programme, 
input to study design, 
interpretation and 
manuscript 
development.   
 
231 Input to public health policy in 
England and Wales and referenced in 
multiple international studies.  
Outputs reported by lay media as 
well as scientific press.  
UNICEF UK 
7 Publication #6  
 
Pavey TG, Taylor AH, Fox KR, Hillsdon 
M, Anokye N, Campbell JL, Foster C, 
Green C, Moxham T, Mutrie N, Searle 
J, Trueman P, Taylor RS. Effect of 
exercise referral schemes in primary 
care on physical activity and 




Co-lead investigator of 
research programme, 
input to search strategy, 
interpretation and 
manuscript 
development.   
261 Input to health policy on coverage 
and adoption of exercise referral. 
Cited in guidelines developed in 
England, Wales and The United 












systematic review and meta-analysis. 
BMJ, 2011; 4;343:d6462.    
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Publication #7  
 
Anokye NA, Trueman P, Green C, 
Pavey T, Hillsdon M, Taylor RS.  The 
cost effectiveness of exercise referral 






Co-lead investigator of 
research programme, 




development.   
 
58 Input to health policy on coverage 
and adoption of exercise referral. 
Cited in guidelines developed in 
England, Wales and The United 














Anokye NA, Trueman P, Green C, 
Pavey T, Taylor RS. Physical Activity 
and health related quality of life. 








development.   
281 Widely cited in subsequent literature 
on well-being and mental health 












Publication #9  
 
Trueman P & Anokye NA.  Applying 
economic evaluation to public health 
interventions: the case of 
interventions to promote physical 





Led study design, 
analysis and manuscript 
development.   
39 Cited in multiple methodological 
discussion papers intended to guide 














In many cases, these studies represent a significant milestone in understanding the impact of the intervention 
under consideration and have resulted in directly influencing public policy decisions on investing in public 
health programmes. Based on the critique of these studies, recommendations will be posited for future 
evaluations of public health interventions.    
1.2 Objectives  
The thesis is intended to address the following broad objectives.   
• Consider the challenges associated with the economic evaluation of public health interventions;   
• Critically assess the application of economic evaluation methods to public health through a series of 
case studies based on the author’s published outputs;   
• Develop evidence-based recommendations for how future evaluations of public health interventions 
might build on the critique presented.    
Whilst the thesis will primarily provide a critique of economic evaluations of public health interventions, it is 
hoped that it will illustrate how the methods applied have developed over time to improve accessibility for 
decision makers, based on continuous learning. It is also intended to provide some guidance for researchers 
on how to justify the most appropriate methods for economic evaluation of public health interventions.   
1.3 Structure of the thesis  
The thesis will start with an introduction to the economics of public health interventions to provide context.  
This will include reference to best practice guidelines for economic evaluations of public health interventions 
as well as critical evaluations of alternative methods of cost effectiveness analysis. Chapter 3 will provide 
further context by considering research into the use of health economics by decision makers. Whilst not 
restricted to public health interventions, this study was a critical study in the author’s development, 
highlighting the need for economic methods to be accessible to healthcare decision makers. Chapters 4 to 7 
will consider applied economic evaluations of public health interventions conducted by the author. These 
evaluations were conducted on behalf of the National Institute for Health and Care Excellence (NICE), the 
National Institute for Health Research Health Technology Assessment programme (NIHR HTA), UNICEF and the 
Counterweight programme.  These represent a significant body of applied economic research on public health 
interventions and illustrate continued development in the methods to ensure that they are accessible and 
relevant to decision makers. Finally, Chapter 8 will provide reflections on the content as well as 




A summary of the chapter headings is provided below:   
Chapter 2: the economics of public health interventions.   
Chapter 3: Research into the relevance of health economics to decision makers.   
Chapter 4: The application of cost utility methods to weight management interventions.  
Chapter 5: The application of cost effectiveness analyses to environmental interventions to promote physical 
activity.  
Chapter 6: The application of cost-benefit analysis to interventions to promote breastfeeding.  
Chapter 7: The application of economic evaluation to exercise referral schemes to promote physical activity.  
Chapter 8: Summary, recommendations & conclusions. 
  
The next chapter will provide context by describing public health interventions and outlining the challenges 
inherent in economic evaluations of such interventions.   
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Chapter 2: The economics of public health interventions  
  
This chapter is intended to provide context for the thesis by defining public health interventions and 
considering how evidence can be generated on their effectiveness and cost effectiveness.    
2.1. What is a public health intervention?  
Public health interventions are intended to ‘promote or protect health or prevent ill health in communities or 
populations’ (Rychetnik et al 2002). In some instances, interventions may seek to improve health across the 
entire population, for example through air quality regulations, whilst in others the intent might be to influence 
health in a sub-group of the population such as interventions to promote healthy eating in children. Such 
interventions may seek to directly promote health, for example through vaccination to protect against future 
illness, or indirectly through affecting a determinant of health, such as tobacco consumption or the changes 
to the physical environment.   
Successive policy initiatives have spoken to the importance of health promotion and the prevention of ill-
health, distinct from the treatment of ill-health (Marmot 2020). Commentators have also pointed out that 
healthcare provision is a less important determinant of health than individual behaviours and the environment 
(McGinnis et al 2002), yet the spending of health budgets seems to be in conflict with the majority of spending 
going to managing, rather than preventing, ill-health. Indeed, it has been previously stated the focus of the 
National Health Service on the treatment of ill-health means it would be better described as a National 
Sickness Service, rather than a National Health Service (Heath 2007).  
The World Health Organisation suggests that the major determinants of health care relate to the social and 
economic environment, the physical environment and the person’s individual characteristics and behaviours 
(World Health Organisation 2020). Combined these factors contribute to a significant number of global 
preventable deaths. For example, nine environmental and behaviour risk factors account for 45% of all global 
cancer deaths, eight behavioural factors account for 75% of all deaths related to coronary heart disease whilst 
unhealthy or unsafe environments are responsible for 1 in 4 of all childhood deaths globally (World Health 
Organisation 2011).   
It is estimated that preventable diseases result in over 130,000 premature deaths per annum in England & 
Wales (Office of National Statistics 2020), equivalent to approximately 2.6 million life years lost. In many cases, 
the deaths attributable to diseases associated with smoking, a lack of physical activity, obesity and alcohol 
abuse could be avoided through lifestyle and behavioural changes. These preventable diseases create a 
significant economic burden to the health service; obesity alone is estimated to cost the National Health 
Service over £6 billion per year in treatment costs, obesity related conditions, lost productivity and premature 
death (Public Health England 2017).    
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Despite these dramatic estimates of human and economic impacts, data suggest that only around 3% of total 
health service expenditure is dedicated to public health interventions and that this has decreased following 
the transition of responsibility for public health from the health service to local authorities in 2013 (The Kings 
Fund 2018).    
2.2 Estimating the effect of public health interventions  
It has been suggested that the limited investment in public health interventions results, at least in part, from 
a dearth of evidence on their clinical and cost effectiveness (Wilmott et al 2016). Principles for evaluating 
healthcare interventions are well established and include a widely accepted hierarchy of evidence (Guyatt et 
al 1995). These principles are widely applied in post-hoc critical appraisals of healthcare interventions, Health 
Technology Assessment (HTA) and option appraisals of potential healthcare investments. However, the 
application of these principles to public health interventions is challenging, both from a practical perspective 
and a methodological perspective.    
The hierarchy of evidence holds that the randomised controlled trial (RCT) is the most robust method to 
estimate causality between a healthcare intervention and an outcome. The principles of the RCT that lead to 
this conclusion are a) randomisation can eliminate selection bias; b) blinding can eliminate observational bias 
and c) the comparator provides a control group.    
There is widely held perception that RCTs of public health interventions are difficult and infrequent but this is 
very much dependent on the nature of the intervention. Weatherly and colleagues undertook a review of 154 
published economic studies of public health interventions conducted between 2000-2005 (Weatherly et al 
2009). Of these, 58 studies (38%) were based on randomised controlled trial evidence although it should be 
noted that these were typically studies of individual level interventions designed to change health behaviours, 
such as smoking or physical activity. Where public health interventions include more complex and/or 
population level interventions, then there are some more significant challenges to conducting RCTs (Craig et 
al 2008). In some cases, it may be inappropriate or even unethical to randomise participants to an intervention 
where there is overwhelming evidence to suggest that the intervention will result in improved outcomes. For 
example, consider whether participants could be randomised between access to clean or polluted water.   
Similarly, in some cases it may be impossible to ensure that the control group is not exposed to an intervention, 
particularly in the case of population level health promotional interventions, such as clean air initiatives. Even 
if these variables can be controlled, the ability to control for confounding health and lifestyle factors, such as 
increasing public knowledge about the harms of particular behaviours, in the control and intervention group 
may create further complexity. Furthermore, given the nature of many public health interventions, it would 
be impractical to follow-up participants for a long-enough period to fully capture any resulting health benefits. 
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The result is that there may be questions about the degree of attribution between the intervention and the 
outcome.    
The combination of these issues means that many commentators have acknowledged that whilst RCT level 
evidence on public health interventions is desirable it is often unfeasible meaning that observational study 
designs are often used for their evaluation (Frieden 2017). The result is that many assessment bodies conclude 
that their effect may be considered unproven or uncertain at best.   
2.3 Estimating the cost effectiveness of public health interventions   
In addition to calls for more robust evidence on the effectiveness of public health interventions there have 
also been demands for better economic evidence to justify their cost (Wilmott et al 2016). From an economic 
perspective, the decision to invest in public health programmes should not be treated differently to 
investment in any other healthcare intervention. As with all investment decisions the principles of scarcity and 
choice should be considered. Given that healthcare budgets are finite (scarce) then choices have to be made 
in how to allocate the available funds to ensure that the available resources are used effectively. Allocating 
funds to public health interventions is associated with an opportunity cost and it is important that these 
investments can be objectively justified with economic evidence to illustrate that resources could not be 
deployed more effectively elsewhere.   
There are multiple methods of economic evaluation applied to healthcare (these are sometimes collectively 
referred to as cost benefit analyses although there are discrete forms of economic evaluation within this 
definition).  The main methods include:   
Cost benefit analysis (CBA): a comparison of costs and benefits with both valued in monetary units;   
Cost utility analysis (CUA): a comparison of costs and benefits with costs valued in monetary units and benefits 
typically valued in quality adjusted life years or a similar composite unit of life expectancy and quality of life;   
Cost effectiveness analysis (CEA): a comparison of costs and benefits with costs valued in monetary terms and 
outcomes valued in natural units, such as life years;   
Cost minimisation analysis (CMA): a comparison of costs in monetary units with the assumption that outcomes 
of competing interventions are identical;   
Cost consequence analysis (CCA): a comparison of costs and benefits with costs reported in monetary units 
and benefits reported in disaggregated natural units.    
The application of cost benefit techniques to healthcare was envisaged as a rational framework for prioritising 
the use of healthcare resources within a budget constraint and delivering good value for money (Russell 2015). 
The initial application of economics to healthcare was dominated by attempts to apply cost benefit analysis 
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techniques, as used in other sectors, or cost effectiveness analyses, reporting the costs of competing 
interventions in monetary units and outcomes typically quantified in natural units, for example life years or a 
change in blood pressure. Over time, methodologists recognised that the use of natural units to report 
outcomes was helpful when comparing similar interventions but was more challenging when comparing 
investment decisions that might result in different outcomes. In order to increase the portability of findings, 
methods emerged to develop a ‘common currency’ for outcomes, capable of capturing impacts on both quality 
of life and quantity of life. These two vectors were most commonly combined into a Quality Adjusted Life Year 
(QALY) or disability adjusted life year (DALY) which forms the basis for cost utility analysis. A review of the 
published literature on health economics illustrates the increasing prevalence of cost utility studies over time, 
driven in part by the academic community and guidelines for the conduct of economic evaluation (Pitt et al 
2016).   
The increasing prevalence of cost utility analysis also reflects a wider interest in the objective function that 
should be applied to healthcare. The early application of cost effectiveness was founded in the principles of 
Pareto welfare, which assumes that individual utilities should be maximised in order to maximise allocative 
efficiency (Coast 2008). This approach assumes that individuals are best placed to judge their own utility and 
if one individuals utility can be improved without impacting that of another individual, then that decision will 
increase overall utility and represents a rational allocation of resources. However, this approach fails to 
recognise that it is rarely possible to increase individual utility without having an effect on others when 
resources are finite, as is the case in healthcare. Allocating health budgets to one service or patient group 
typically means that other services or patients are denied funding. In this scenario, it would be inappropriate 
to rely on the judgement of individuals to determine how resources should be allocated. Extra-welfarism 
moves the objective function from the individual to society and assumes that decision makers can allocate 
resources in a way that reflects societal preferences. Cost utility analysis, reported in the form of quality 
adjusted life years (QALYs), was intended to be a framework to inform these resource allocation decisions by 
bringing together the costs of an intervention with outcomes based on societal preferences. Whilst the 
principles of this approach are sound, in practice there is evidence to suggest that health maximisation is not 
the sole objective of decision makers and that even if this were the case, cost effectiveness evidence on the 
majority of routinely provided healthcare interventions is not available, meaning decision makers can not rank 
interventions in an informed, orderly way (Coast 2009).     
These methods for the economic evaluation of healthcare interventions have developed largely through their 
application to pharmaceuticals and medical technologies which are typically supported by robust clinical trial 
evidence to illustrate their effectiveness. Their application to non-pharmaceutical interventions, and 
specifically public health interventions, is associated with some major challenges. Weatherly et al (2009) 
summarised these challenges in four main categories:   
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• Attribution of effects;   
• Measuring and valuing outcomes;   
• Identifying intersectoral costs and consequences;   
• Incorporating equity considerations.   
 Public health interventions are often associated with a paucity of data or significant uncertainty around their 
effectiveness and an inability to control for confounding variables. This is compounded by the fact that many 
of the outcome benefits may be accrued many years in the future and there may be uncertainty in the 
relationship between short-term proxy endpoints captured in studies and longer term outcomes (for example: 
a change in physical activity and the future incidence of cardiovascular disease).   
Thirdly, both the costs and benefits of public health interventions may accrue to health and non-healthcare 
decision makers. Adopting a narrow, health service perspective and outcome, such as the QALY, fails to 
capture the full benefits of many public health programmes and is likely to be poorly understood by 
stakeholders from non-health sectors. Such an approach also assumes that the objective function of all 
decision makers is health maximisation. For some decision makers, their objectives may be very different, for 
example, whilst changes to the built environment might consider the potential to improve physical activity 
levels the primary intention might be environmental improvements which are not reflected in the QALY. 
Similarly, on the cost side of the equation it is important to consider how costs should be allocated across 
sectors.   
These challenges to the evaluation of public health interventions are less of a concern in the evaluation of 
healthcare interventions, such as medical devices or pharmaceuticals, where the primary outcome of the 
intervention is an improvement in health outcomes. Whilst there may be some indirect benefits, such as 
improving productivity through improved health, these benefits are typically marginal to the primary benefit 
and are often excluded from the assessment of their value.  
Finally, the adoption of a cost utility framework assumes that the objective function of decision makers is to 
maximise health gain across a population, regardless of who benefits. In many cases, public health 
interventions are designed to target individuals with the greatest ability to benefit and outcomes should be 
equity-weighted to reflect this (Cookson et al 2009). This is neatly illustrated in one of the case studies 
presented herein which considers the use of activity trails to promote physical activity. Whilst data illustrate 
that such trails are associated with an increase in net physical activity, it is impossible to determine whether 
the beneficiaries are individuals who were already active or whether these are newly active individuals and 
the degree to which this might impact health inequalities. Incorporating qualitative research methods into the 
evaluation process may offer some valuable insights that help to address these issues. Preferences for the 
distribution of health benefits, perceptions of what constitutes a medical need and the degree to which 
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behaviour change should be the responsibility of the state or the individual could all be explored more 
effectively through qualitative research (Coast 2017). Others have suggested that qualitative research 
techniques could also provide improved understanding of real world decision making processes to inform how 
methods and outcomes should be presented (Smith 2009). Despite this, health economics remains dominated 
by quantitative research methods.  
Many commentators have expressed concerns that the application of cost effectiveness analysis and 
particularly cost utility analysis may be inappropriate when considering complex, population level 
interventions due to the inter-sectoral nature of the costs and benefits (Marsh et al 2012)(Lung et al 
2017)(Brousselle et al 2016). However, Weatherly et al (2009) found that around a quarter of all economic 
evaluations of public health interventions were cost utility analyses reporting outcomes in a QALY or DALY and 
the volume of cost utility studies continues to increase driven by guidelines for economic evaluation.   
2.4 Guidelines for economic evaluation of public health interventions  
Whilst there is an abundance of guidelines on methods for conducting economic evaluations these typically 
apply to pharmaceuticals and/or medical technologies and assume that these interventions are supported by 
robust, trial based evidence (Gold et al 1996) (Huserau et al 2013) (Drummond & Jefferson 1996). A number 
of reviews have considered the applicability of these methodological guidelines to public health interventions 
and typically concluded that they may have limited relevance (Lung et al 2017).   
A systematic review to identify guidelines specific to the economic evaluation of public health interventions 
identified 16 relevant guidelines, 12 of which were from UK or international bodies and 4 were independently 
authored (Tudor-Edwards et al 2013). These guidelines included recommendations specific to healthcare as 
well as guidelines for a broader range of public sector investment decisions. There were also a number of 
guidelines which relate to evaluation methods more generally, such as social return on investment models.     
From a UK perspective, the NICE methods for public health guidance provide recommendations for economic 
evaluations (National Institute for Health & Care Excellence 2012). This recommends that economic evaluation 
should be conducted if there is no existing, reliable economic data and there is an expectation that there will 
be a net benefit associated with the intervention. The preferred method of evaluation is cost utility analysis, 
in line with other work programmes conducted by NICE, with the QALY being the preferred endpoint. The 
guidance does acknowledge that other approaches may be relevant, including cost benefit analysis and cost 
consequence analysis, particularly where far-reaching societal impacts may occur.   
A second review article (Lung et al 2017) considered two guideline documents for economic evaluation of 
public health; the NICE guidance referred to above (National Institute for Health & Care Excellence 2012) as 
well as guidance from the Centres for Disease Control and Prevention (CDC) in the United States (Department 
of Health and Human Services Assistant Secretary for Planning and Evaluation, 2006). As with the NICE 
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guidance, the CDC promotes the adoption of CUA as the primary method, with cost benefit analysis and cost 
effectiveness analysis also considered. A more recent discussion paper on behalf of the CDC (Russell & Sinha 
2016) has explored this issue further, highlighting that health economists, with their adherence to CUA 
principles, should learn from cost benefit analysis methods to ensure that they can capture non-health impacts 
more effectively. The guidance continues to point towards CUA as the preferred methodology, albeit with 
some caution.    
Guidelines can play a powerful role in methods development and application. As a result of the NICE guidelines 
there has been a significant increase in the volume of cost utility analyses of public health interventions over 
the last decade. The methods guidance also creates a risk of systematic bias in published evaluations, by 
suggesting that economic evaluations should only be carried out where there is an expected net benefit of the 
intervention. A review paper by staff from NICE made the bold claim that the majority of public health 
interventions are ‘highly cost effective’ based on analyses conducted as part of guidance development (Owen 
et al 2018). This fails to acknowledge that the methods guidance recommends that evaluations were only 
developed where there was an intrinsic belief that the interventions would deliver a net benefit to the health 
service – the guidance states that economic evaluation is not required where there may be challenges in 
estimating costs and benefits – resulting in an inherent bias in analyses conducted for guideline development.  
This study also reports the aggregated cost per QALY ratio and fails to consider the absolute incremental 
differences in costs and QALYs that were identified.  In the majority of case studies reported herein, the perils 
of the cost per QALY ratio will be explored, highlighting that a point estimate can be fundamentally unstable 
when the absolute differences in costs and/or QALYs are close to zero or negligible.  In such cases, there is a 
danger that spurious accuracy in the measurement of the costs and/or health benefits may not be fully 
acknowledged in the point estimate of the ICER. Even where sensitivity analysis is conducted, this often 
involves applying an arbitrary distribution to a point estimate which may not address the fundamental 
uncertainty of the point estimate value.   
These challenges in applying cost utility analysis to public health interventions will be explored in the applied 
economic evaluations presented in the following chapters.  
   
2.5 Chapter Summary  
This chapter highlights the importance of public health interventions in addressing the determinants of health 
but acknowledges that one of the causes of limited investment in such interventions is the absence of 
highquality economic evidence to illustrate their value. Some of the theoretical challenges associated with 
applying cost utility analysis to public health programmes are introduced were introduced and these will be 
explored in more depth through applied research in the following chapters. The case studies presented will 
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consider the relative merits of alternative approaches to economic evaluation, specifically cost consequence 
analysis, and whether this might help to improve the quality and accessibility of public health evaluations.   
Before introducing the applied economic evaluations the next chapter will provide further context for the 
thesis by examining an early publication by the author. This study sought to understand the relevance of 
economic methods to decision makers and was influential in the shaping how the author approached applied 




Chapter 3: Research into the relevance of health economics to decision 
makers   
Publication 1: Duthie T, Trueman P, Chancellor J, Diez L. Research into the use of health economics in 
decision making in the United Kingdom--Phase II. Is health economics 'for good or evil'? Health Policy. 1999 
Jan;46(2):143-57.   
Available at: https://www.sciencedirect.com/science/article/abs/pii/S0168851098000578 
 
This chapter considers research into the use of economic evaluation by health service decision makers.  
Although not restricted to public health, the research considers the applicability of multiple economic 
evaluation methods and the degree to which decision makers can understand the findings. This research was 
a powerful motivation in attempting to conduct applied economic evaluations that are accessible and easily 
understood by decision makers and helped to shape not only the evaluations presented herein but the overall 
objectives of the thesis.    
 
3.1 Study context  
The raison d’etre of health economics is to inform healthcare decision makers faced with demands which 
exceed the available resources. Economic evaluation has the potential to inform decisions on the value of 
competing investments and ensure that budgets are prioritised to those interventions which are proven to be 
cost effective (Russell et al 1996). In certain instances this is done in a systematic and explicit fashion, such as 
through the use of health technology assessment (Culyer 2018), whilst in other cases its application may be 
less transparent or less explicit which might result in less efficient allocation of resources (Torbica et al 2020).   
Whilst the volume of economic evaluations in healthcare has increased exponentially over recent decades (Pitt 
et al 2016) there has been relatively little research to assess the impact of these evaluations and whether they 
meet the needs of healthcare decision makers.    
One of the few studies to do so was a qualitative research study conducted by the author (Duthie et al 1999) 
which sought to understand whether the typical outputs of health economic evaluations are relevant to 
decision makers and how the methods and presentation of health economic research could be improved to 
increase their impact. This was a critical study in the authors development, as it highlights that many of the 
concepts, methods and outcomes used by health economists are poorly understood by healthcare decision 




3.2 Methods  
A qualitative research study was conducted with a purposive sample of stakeholders from the English NHS.  
The stakeholders were selected on the basis that they influence or contribute to decisions on the adoption of 
healthcare interventions. Participants included primary and secondary care physicians, pharmacists, and 
hospital and community care managers. Whilst attempts were made to capture stakeholders from across the 
geography of the NHS, the resulting sample of 34 participants might be considered a purposive sample of 
relevant stakeholders. Semi-structured interviews were conducted face-to-face with stakeholders in pairs 
lasting approximately 90 minutes.    
For the purposes of the study, a series of 44 vignettes describing the outcome of hypothetical economic and 
outcome studies were developed (for example: ‘Antibiotics A and B are equally effective but when all costs 
are taken into account, A works out cheaper despite costing more per tablet’). In most cases, the vignettes 
included a perspective on both costs and benefits to provoke conversation about how useful these would be 
in allocating scarce resources. However, in a few cases outcomes referring to just cost or benefits were stated 
to see if this led to participants raising the issue of scarce resources (for example: 80% of patients said they 
preferred Treatment A to Treatment B). These outcome vignettes were selected randomly as a basis for 
discussion between the interviewer and the participants to explore the relevance of the outcomes to 
participants and understand positive and negative reactions to the concepts presented.    
3.3 Data  
A total of 34 participants were included in the study, 14 from general practice, 14 from secondary care and 6 
from regional managerial positions. In total 17 healthcare professionals comprising primary and secondary 
care physicians and pharmacists participated and 17 managerial professionals although it should be noted that 
in some instances the healthcare professionals also had budgetary responsibility whilst some of the 
managerial professionals had previously practiced medicine.   
Given the semi-structured nature of the research and the relatively small sample size, formal qualitative 
synthesis methods, such as key word searches were not applied. However, methodical qualitative analysis of 
interviews resulted in thematic responses to the economic outcomes presented and there was some degree 
of consensus amongst participants to many of the messages. Following thematic analyses, an attempt was 
made to categorise the vignettes into ‘some degree of relevance’ to participants and ‘no degree of relevance’.  
3.4 Results  
Of the 44 economic vignettes presented, 29 were felt to have ‘some degree of relevance’ to the participants, 
with remaining 15 being regarded as irrelevant by decision makers. Of the 15 irrelevant cases:   
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• 9 were rejected on the grounds that the benefit was not considered worthwhile – these included 
patient convenience/preference, patients returning to social functioning or emotional well-being;   
• 3 were rejected because they were not understood – these included outcomes presented as numbers 
needed to treat, quality adjusted life years and cost-benefit ratios;   
• 3 more were rejected by the method was deemed questionable – these included outcomes of 
willingness to pay and time-trade off studies.    
Whilst the participants were, in some cases, critical of economic methods and the presentation of outcomes 
there was a consensus that some form of economic evaluation was required in a resource constrained health 
system. There was some frustration expressed at the methods for attempting to quantify all resources (such 
as staff time) in monetary units and the resulting difficulty to realise any ‘savings’ on a balance sheet. Related 
to this, participants suggested that health economists needed a better understanding of the mechanics of 
health service financing mechanisms to ensure that findings were presented in a way that could be put into 
practice.  
When interpreting the messages, healthcare professionals were typically more attracted to outcomes 
presented at an individual level, rather than outcomes aggregated across a population. Similarly, stakeholders 
tended to be more attracted to outcomes which were of direct relevance to their practice or facility. For 
example, primary care physicians were less interested in outcomes which may benefit the secondary care 
provider. One over-arching comment was the mistrust of ‘jargon’ and the tendency for health economists to 
use complex terms to quantify the outputs of their studies, such as QALYs.    
3.5 Strengths & weaknesses  
It was recognised at the time that the qualitative, in-depth interview methods adopted in this study would 
limit the number of participants. As such, it would be difficult to include a sample of participants that would 
truly represent the NHS. However, some attempts were made to stratify the sample across healthcare 
professionals and managers, the geographical regions of the NHS and primary and secondary care. 
Furthermore, the semistructured interview format was adopted to allow for wide-ranging conversation and 
generate ideas on how health economic methods and reporting might be improved. The downside of such an 
approach is that the interpretation relies on thematic analyses rather than more formal, qualitative research 
methods.    
3.6 Critical appraisal  
This study was influential in considering the applicability of health economics to decision makers and was 
widely referenced by subsequent studies which further explored the theme (Hoffman & von der Schulenberg 
2000). The study illustrated that many of the methodological constructs used in health economics, including 
25 
 
cost utility analysis and willingness to pay, were alien to front-line health service decision makers and the 
presentation of the outcomes in this fashion was unhelpful to informing resource allocation. The findings were 
prescient in concluding that more standardised approaches to health economics may help to improve 
applicability and understanding amongst decision makers. Shortly after this publication, a professional group 
task force was developed to explore this issue (Ramsey et al 2005) and the National institute for Health & Care 
Excellence (NICE) established their ‘reference case’ for health economic evaluations(National Institute for 
Health & Care Excellence 2013). Undoubtedly, such initiatives helped to drive more consistency in the methods 
applied and, in doing so, improve familiarity with health economics amongst healthcare decision makers.    
Whilst consistency is helpful it needs to be accompanied by improved understanding to avoid decision-makers 
adopting a ‘tick-box’ approach to evidence. Where an economic evaluation is conducted in line with guidance 
decision makers may be inclined to accept the methods as robust and consider only the outputs, such as the 
cost per QALY and determine whether this falls within an acceptable threshold. Although NICE was initially 
reluctant to define a threshold for what constitutes a cost effective intervention, a number of studies sought 
to identify the de-facto threshold by examining the cost effectiveness of interventions that were 
recommended for routine use in the NHS and those that were restricted (Devlin & Parkin 2004). The danger 
of such an explicit threshold is that decision makers blindly ‘accept’ interventions that are deemed to fall below 
it without fully understanding how the cost effectiveness ratio has been derived and the level of uncertainty 
around a point estimate.    
Examination of the public health interventions in this thesis will highlight a number of examples where the 
incremental cost effectiveness ratio was deemed to be ‘acceptable’ but both costs and/or outcomes were 
close to zero and subject to significant uncertainty. The result is that the point estimate of cost effectiveness 
is sensitive to small changes in input parameters which can result in a range of outcomes, from cost neutrality 
to cost effectiveness to cost ineffectiveness depending on assumptions about critical inputs.   
The study also highlights some of the practical challenges with interpreting the commonly used outcomes of 
economic evaluations. Aggregating costs and outcomes into a single vector (an ICER value) creates two 
significant problems for decision makers. Firstly, decision makers typically operate with budget silos and need 
to know how their budget will be affected, rather than the aggregated health service (or even societal) budget.  
As such, it is important to illustrate where costs and outcomes are accrued. Secondly, the ICER is essentially a 
linear function which may provide the same ratio for two interventions that provide very different absolute 
levels of cost and benefit.    
In spite of the results of this study, and several other studies conducted around the same time with similar 
conclusions (Walley et al 1997) (Williams & Bryan 2007) (Eddama & Coast 2008), health economists have 
continued to promote the use of advanced methods of health economics, particularly cost utility analysis, 
through best practice guidelines. Indeed, over time the complexity of these methods has developed further 
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arguably driven by academic pursuits rather than a desire to make the findings more applicable to decision 
makers, for example through probabilistic sensitivity analyses and value of information analyses (O'Hagan et 
al 2005). A more recent qualitative study looked specifically at the use of health economics in local authority 
decision making on public health interventions (Frew 2020). Whilst this suggests that familiarity with health 
economic concepts may have improved since the author’s publication, there remain some significant 
challenges in applying economic evaluations to real-world policy decisions, mainly due to the narrow 
perspective, protocol driven events and long time horizons that are typically adopted. It is frustrating that 
health economists have failed to react to these studies by improving the accessibility of their methods and 
outputs. The remainder of this thesis will reflect on this issue and explore the practical application of multiple 
methods of economic evaluation to public health interventions.  
  
3.7 Chapter summary   
The study in this chapter is presented as context to the following chapters. This research was pivotal in forming 
the ideas which make up much of the remainder of this thesis. The desire to produce economic outcomes 
which resonate with the end-user and inform decision making underlies the majority of the studies which are 
discussed herein. This is particularly pertinent in public health planning where multiple stakeholders are 
involved in planning and deployment.   
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Chapter 4: The application of cost utility methods to weight management 
interventions.  
Publication #2 Trueman P, Haynes SM, Felicity Lyons G, Louise McCombie E, McQuigg MS, Mongia S, Noble  
PA, Quinn MF, Ross HM, Thompson F, Broom JI, Laws RA, Reckless JP, Kumar S, Lean ME, Frost GS, Finer N, 
Haslam DW, Morrison D, Sloan B; Counterweight Project Team. Long-term cost-effectiveness of weight 
management in primary care. Int J Clin Pract. 2010 May;64(6):775-83.   
Available at: https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1742-1241.2010.02349.x 
 
This chapter presents the author’s first applied case study of an economic evaluation of a public health 
programme to promote weight loss. Throughout the case studies, I will consider not only the applicability of 
the methods adopted but also the accessibility of the results, reflecting on some of the lessons learned from 
the study reviewed in the previous chapter. This chapter considers two alternative approaches to the 
evaluation of a weight management intervention. The first is a cost utility analysis with a lifetime horizon 
whilst the second is an attempt to provide a more granular estimate of the short-term impact of the 
intervention, recognising that decision makers typically operate under short-term budget constraints.   
4.1 Study context  
The prevalence of obesity in the majority of Western countries is increasing, leading to the Organisation for 
Economic Co-operation and Development (OECD) to refer to an ‘obesity epidemic’ (OECD 2017). In their latest 
report on the issue, the OECD estimates that nearly one in two adults and one in six children living in OECD 
member countries are obese or overweight. Obesity is a recognised risk factor for a number of long-term 
conditions including diabetes mellitus, coronary heart disease and a number of cancers (Kinlen et al 2018).    
Unsurprisingly, given these trends, there has been significant interest in the economics of weight 
management. A number of studies have attempted to quantify the economic burden of obesity to the NHS 
and society more broadly (Allender & Rayner 2007) (UK Government Office of Science Foresight 2007) 
(Scarborough et al 2011). As well as studies seeking to quantify the economic burden of obesity, there has 
been a significant body of evidence published assessing the clinical and economic effectiveness of weight 
management interventions (Loveman et al 2011).    
4.2 The Counterweight Programme  
Counterweight is an evidence-based weight management programme, delivered in general practice settings 
for patients who are at risk of weight gain or already considered overweight or obese (The Counterweight 
Project Team 2004). The programme was established in 2000 through a collaboration between leading 
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academics with expertise in weight management, nutrition, endocrinology and behavioural sciences. The 
programme is provided by practice nurses or primary care staff, supplemented by specialist weight 
management advisors qualified in diet and/or nutrition. The programme consists of behavioural strategies 
intended to help participants to manage their diet and lifestyle, with the goal of achieving a realistic weight 
loss of 5-15% of body mass. Critically, the behavioural strategies employed are intended to produce a 
sustained impact, unlike other weight management interventions which have been shown to result in cycles 
of weight loss followed by weight gain (Chambers & Swanson 2012).   
A number of robust, clinical trials have shown the Counterweight programme to be effective in promoting 
weight loss (The Counterweight Project Team 2008). Indeed, the programme has recently garnered significant 
attention due to the DiRECT study results which indicated that a more intensive form of the Counterweight 
programme can help sustain remission of diabetes (Lean et al 2019).    
Despite the quality of the clinical evidence to support the programme, there remain challenges to funding 
such an intervention, particularly given the number of potentially eligible participants. An economic evaluation 
was conducted to provide insights into the cost effectiveness of the Counterweight programme (Trueman et 
al 2010). This study built upon an economic model that was originally developed to inform the development 
of NICE guidelines on weight management interventions. The model was adapted to consider the cost 
effectiveness of the Counterweight programme by incorporating evidence from the trials referred to above.    
4.3 The model structure  
The economic model attempts to estimate the long-term impact of weight gain on outcomes and healthcare 
resource use. A micro-simulation model was designed to predict weight change over time and the resulting 
impact on long-term outcomes. Micro-simulation models essentially model the trajectory of an individual and 
then repeat this multiple times, simulating a cohort of individuals, to recognise the uncertainty around many 
of the variables that may affect outcomes. The average results for the cohort of individuals are then presented.   
In the current simulation, an individual either gained weight, lost weight or remained in a stable weight over 
time. However, the trend across the overall cohort was for weight gain, reflecting the trend across the 
population as a whole. The weight of each individual is simulated in the model on a 6 monthly basis – hence 
an individual whose weight remained stable over one 6 month period could gain or lose weight in the following 





Figure 4.1: Schematic of the model of weight management interventions (reproduced from Trueman et al  
2010)  
  
Changes in weight impact on the healthcare resource use of individuals, their quality of life (utility) and their 
likelihood of developing obesity related conditions. Conditions considered in the model were limited to 
diabetes mellitus, coronary heart disease and colon cancer. Whilst other studies have pointed to an association 
between weight gain and other conditions, the evidence on the lifetime risk of these conditions was deemed 
to be insufficient to include in the model. Where an individual develops an obesity related condition, 
disutilities and healthcare resource use associated with this condition are factored into the model along with 
any impact on mortality.   
4.4 Data  
Simulation models offer some distinct advantages for modelling long-term conditions which have complex 
relationships with multiple potential outcomes. However, it should be recognised that simulation models are 
also ‘data-hungry’, demanding multiple data points. Critical data inputs in the current model are detailed 
below.    
1. Population characteristics: these were derived from the Office of National Statistics and the Health 
Survey for England.   
2. Data on underlying weight gain: the absolute weight gain adopted in the model was an average of 
1kg/yr, based on observational studies from Denmark and the United States.    
3. Data on the impact of weight gain on long-term conditions: the relationship between BMI and the 
obesity related conditions considered in the model were all derived from published sources.    
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4. Data on effectiveness of Counterweight programme: Data on the effectiveness of Counterweight were 
derived from clinical trials. (The Counterweight Project Team 2008)  
5. Data on unit costs and utilities: both were derived from previous studies.   
A number of scenarios were modelled which considered alternative assumptions about the duration of effect 
of the intervention and the degree to which any weight loss was sustained.   
4.5 Outcomes  
In the base case, the Counterweight programme is assumed to result in an average of 3kg weight loss at 12 
months, as illustrated in the clinical trial data. It was assumed that any participants that did not present for 
follow-up in the Counterweight programme (55%) did not lose any weight. Furthermore, it was assumed that 
any weight loss over the 12 month period would be gradually regained over the following 2 years, so any 
impact on healthcare resource use and outcomes was time limited. The resulting cost effectiveness analysis 
suggested that under these scenarios the Counterweight programme was a dominant intervention.  Compared 
to no intervention it resulted in a lifetime saving of £27 and an increase in utilities of 0.06.    
Sensitivity analyses were conducted around some of the structural and parameter uncertainties in the model. 
Two major aspects of the model were varied in sensitivity analyses – firstly, the assumed underlying trend for 
weight gain in the general population and secondly the degree to which any benefit from the Counterweight 
programme lasts beyond the 12 month period reported in the trial data. In the first case the underlying weight 
gain was reduced from an average of 1kg/yr to 0.5 kg/yr and then 0.3kg/yr. In the latter case, the base case 
model assumes that any weight lost as a result of the Counterweight intervention is regained over 2 years 
whilst a ‘best case’ scenario assumes that weight loss is sustained over the individual’s lifetime.    
Sensitivity analyses resulted in the expected changes – reducing the underlying weight gain in the population 
worsened the cost effectiveness of the intervention (from dominant to ~£2000/QALY, whilst the best case of 










Table 4.1: Summary of sensitivity analyses (reproduced from Trueman et al 2010)  
   
Footnote:  
*Base case assumes any weight loss at 2 years is regained over 1 year following intervention; Best case assumes any weight loss at 2 
years is maintained following intervention.  
ϮDominant indicates improved outcomes at lower cost than comparator 
4.6 Strengths & weaknesses  
The cost effectiveness of the Counterweight programme was a significant economic study of weight 
management interventions. Whilst previous economic studies had been published, the Counterweight study 
utilised robust randomised controlled trial evidence as its source data. Furthermore, the efforts to incorporate 
the risk of future, obesity related conditions ensured that the model provided a holistic view of the costs and 
benefits associated with obesity. This is important as the costs of managing obesity per se are relatively 
modest compared to the cost of managing obesity related conditions, such as diabetes and coronary heart 
disease.   
A number of obvious limitations were acknowledged at the time of developing the model. Firstly, the 
assumption about the rate of underlying weight gain in the population was derived from an observational 
cohort assumed to be representative of the UK adult population. Secondly, the number of conditions 
associated with obesity was limited to three to reduce any material uncertainty in the model. Whilst a number 
of other conditions are known to be associated with obesity, the data on this relationship at the time of model 
development was limited so these were excluded. Finally, the disutilities and costs associated with each of 
these conditions were derived from previously published sources, again, assumed to be of relevance to the 
NHS treated population. In some cases, these were derived from international literature or studies which may 
have limited external validity.   
4.7 Critical appraisal  
In addition to the limitations acknowledged at the time of the study a number of important methodological 
and policy lessons were derived from the study. Methodologically, simulation modelling was a practical 
solution to the challenges inherent in modelling lifetime costs and outcomes. However, from a face-validity 
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perspective it can create some challenges in interpreting and communicating results to a non-economist. The 
model is incapable of applying a ‘memory’ to an individual’s weight trajectory. As such, over any 6-month cycle 
an individual may lose weight, gain weight or remain at a stable weight, regardless of their previous 6 months.  
This is modified by running the model for a large cohort of individuals (in this case 10,000) which results in 
‘average’ weight trends across a population. However, difficulties remain in explaining that the model will 
generate individuals with unpredictable – and some might say, unrealistic – weight patterns over their lifetime.   
The second major challenge associated with simulation modelling is the unpredictability of the outcomes. The 
model generates a cohort of 10,000 individuals each time it is run, with distributions around each parameter 
value for these individuals. The result is that running a model twice, with the same input value, will result in 
two different outcomes. Now this is not a major issue if there is a significant difference in costs and outcomes 
between the intervention and the comparator. However, it becomes more meaningful when the differences 
are marginal – are the differences occurring due to a material improvement from the intervention or simply 
as a result of the model sampling unevenly from the parameter distributions? In the case of the current 
analysis, this is a genuine concern as the lifetime differences in costs and utilities were both marginal and some 
would argue, close to zero. In this case, minor changes in parameter distributions used in the model could 
move the outcome from being dominant to cost effective or even cost ineffective.    
Related to the above, are challenges in communicating the outcomes of the analysis. The clinical data on the 
Counterweight programme are powerful. Most clinicians would agree that a 3kg weight loss over the course 
of a year is clinically meaningful. However, to extrapolate this over the course of a lifetime requires some gross 
assumptions and in doing so may actually undermine the value of the intervention. Arguably, the absolute 
weight loss reported in the trial may be more impactful to decision makers than a lifetime QALY gain of 0.06 
which may be hard to comprehend and seem negligible over the course of a lifetime. Similarly, the estimated 
lifetime cost saving of the intervention was £23 in the base case which may be considered as negligible.   
Whilst economic data are necessary to support further investment in public health programmes, the danger 
in this instance is that an intervention with high quality clinical data is undermined by economic 
methodologies. In attempting to estimate lifetime benefits, a number of gross assumptions were required 
which could be open to criticism. Furthermore, whilst the composite outcome (a dominant ICER) appears 
favourable, both the lifetime difference in costs and QALYs is marginal – some might say negligible.    
In light of this, a second study of the Counterweight programme – described below - was conducted with the 
intent of identifying short-term, tangible savings that may result from improved weight management.   
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4.8 Study context  
A second evaluation of the Counterweight programme adopted a narrower and shorter-term perspective 
(The Counterweight Project Team 2008). This partial analysis considered the impact of obesity and weight 
gain on prescribing costs. This narrow perspective was adopted as the Counterweight programme was 
typically funded through the prescribing budget, hence any cost savings identified through the analysis might 
be used to offset the cost of the intervention. This also recognises that prescribing costs might be considered 
a flexible cost that can be changed with immediacy, whereas many other healthcare costs, such as labour 
and hospital costs, might be considered sunk costs which can only be changed over a longer period. This 
approach was also intended to provide potential short-term savings to healthcare budgets, acknowledging 
that decision makers can rarely invest now to save later, as predicted by models which adopt lifetime 
horizons.     
4.9 Methods  
This analysis estimated the relationship between prescribing costs and BMI, with a view to then estimating 
how the Counterweight programme can reduce prescribing costs. Attempts were made to generate a sample 
of patients that were broadly representative of the UK population. Records were derived from a random 
sample of 23 general practices, stratified geographically across the UK health service regions (at the time). A 
random sample of obese patients (BMI>30) was derived aged between 18-75 year. Following this, a sampling 
framework was developed to generate cohorts of patients with normal weight (BMI<25) and overweight 
(BMI 25-30). Cohorts were matched by age and sex in an attempt to improve comparability. The resulting 
cohort included 3,400 patients across the three BMI categories. Data on prescribed items over an 18 month 
period between 2000-2002 was then derived from patient notes. The costs of prescription items were 
derived from the National Formulary. Multivariate regression analyses were used to determine the 
probability of prescribing and the associated costs based on reported BMI.   
Based on the above, the cost effectiveness of the Counterweight programme was modelled. This assumed 
that individuals without access to Counterweight would gain 1kg per year on average, whilst outcomes for 
those on the Counterweight programme were based on the reported trial results. The costs of the  
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Counterweight programme assume that participants attended at least 6 sessions over a 12-month period.  
Prescribing of medications primarily intended for the treatment of obesity (as distinct from the management 
of obesity related conditions) were also included, based on rates reported in the trials. Outcomes considered 
whether the incremental costs of providing the Counterweight programme could be offset by savings in the 
prescription budget. A base-case considered all prescribing costs whilst a secondary analysis considered only 
the ‘top-ten’ most commonly prescribed items.    
4.10 Outcomes  
There was a clear relationship between the incremental cost of prescription items and BMI. In men, the 
prescription cost increased from £50.71 in men with a BMI of 18.5-20 to £198.66 in men with a BMI >40. 
Similarly, in women the costs increased from £62.59 to £160.73.   
The impact of the Counterweight programme was estimated by considering a sample of patients with BMI of 
37 (similar to those in the Counterweight trial). The Counterweight programme was estimated to cost £60 
per participant. The analysis predicts their prescribing costs with and without the Counterweight programme 
over a 1 and 2-year follow-up. The results suggest that savings on prescribed items would equate to around 
£6.35 for men and around £3.75 for women or approximately 8% of the cost of the Counterweight 
intervention at one year follow up. Extending the analysis to two years the savings on prescribed items 
increased further, offsetting around 18% of the intervention cost. Assumptions about improved compliance 
with the programme increased this further to 22%. Scaling these results to the UK population resulted in 
potential savings of between £40M and £52M in obesity related prescribing costs.    
4.11 Strengths and weaknesses  
A number of limitations were recognised at the time of the analysis. Efforts were made to ensure that the 
sample of patients considered were broadly representative of those treated by the UK NHS. However, the 
degree to which the sample could be stratified for co-variates, such as multiple morbidities, was limited by 
the completeness of the data. Similarly, matching the cohorts of patients categorised as ‘normal’ weight, 
overweight and obese faced the same challenge. With regards to the prescribing rates and costs, data were 
based on reports from patient records and as such are subject to some degree of uncertainty with regards to 
accuracy of the reporting of prescriptions, the fill rate and the degree to which these prescriptions were 
actually used by patients. However, these limitations were unavoidable given the retrospective nature of the 
analysis. Finally, the estimate of the cost effectiveness of Counterweight assumed that patients not 
participating in the programme would – on average – gain weight over time. The estimate of a 1kg increase 
in weight per year mirrors the assumption adopted in the cost utility analysis and is open to the same 
criticisms raised above.   
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4.12 Critical appraisal  
Compared with the cost utility analysis reported above, this second analysis of the Counterweight 
programme adopts a narrower, partial analysis perspective, seeking only to quantify the impact of the 
programme on prescription costs. Whilst a partial analysis explicitly excludes some of the broader impacts of 
the Counterweight programme and the patient benefits, it can help in defining impacts which are material 
and can be realised by decision makers within realistic timeframes. In this instance, it was recognised that 
the Counterweight programme would be ‘prescribed’ to patients and covered through prescription 
pharmacy budgets. The intent of the study was to show that whilst the cost of the programme would 
increase prescribing costs, some of this increase could be offset through reductions in other prescribed 
items. Furthermore, the study avoided any attempt to model future savings which can not readily be offset 
against investments in the current budget year.   
Whilst the partial analysis is considered more applicable for decision makers, the presentation of the results 
remain very complex and it is unlikely to provide the clarity required by decision makers. The multiple 
analyses and assumptions (for example, partial uptake, full uptake, underlying weight loss) make 
interpretation of the findings challenging for any non-economist. These assumptions were necessary to 
acknowledge shortcomings in the available effectiveness data and also an attempt to provide transparency 
about the potential benefits. However, in an attempt to be transparent about the uncertainty in the model 
inputs there is a degree of over-compensation which results in far too many scenario analyses to provide a 
clear message for decision makers. In hindsight, a more succinct outcome could have been generated by 
limiting the number of assumptions and generating a clearer outcome – e.g. approximately 30% of the cost 
of the programme could be offset through savings in prescriptions in the short-term.    
The short-term, partial analysis is believed to offer practical insights into the net budgetary impact of the 
programme to healthcare decision makers. It is also an attempt to move from a lifetime, cost utility analysis 
with limited applicability to decision making to a more pragmatic cost consequence type approach, albeit 
with a narrow perspective limited to prescribing budgets.    
4.13 Chapter Summary  
This chapter provides the first case studies of applying economic evaluation to public health programmes, in 
this case a weight management intervention. Although the intervention was supported by robust clinical 
evidence, adopting a lifetime perspective in the cost utility analysis resulted in marginal costs and benefits 
which are unlikely to be impactful to decision makers. The short-term analysis sought to address this by 
presenting more discrete estimates of the impact on the prescribing budget although, in hindsight, the 
outcomes could have been presented in a more easily digestible format. These studies illustrate how the use 
of a shorter-term economic evaluation, with a narrower perspective may provide results which are more 
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applicable to decision makers than standard cost utility methods. This contrast is further explored in the 
following chapter.    
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Chapter 5:  The application of cost effectiveness analyses to environmental 
interventions to promote physical activity.  
Publication #4.  Beale SJ, Bending MW, Trueman P, Naidoo B. Should we invest in environmental 
interventions to encourage physical activity in England? An economic appraisal. European Journal of Public 
Health, 2012; 22(6): 869-873.   
Available at:  https://academic.oup.com/eurpub/article/22/6/869/542542 
 
This chapter examines a case study of applying economic evaluation to environmental interventions to 
promote physical activity. The research was commissioned by NICE to inform development of public health 
guidance. Whilst methods were largely dictated by the NICE guidelines for economic evaluation, attempts 
were made to incorporate some of the lessons learned from the previous chapter. In contrast with the 
previous chapter, which considered a targeted, individual level intervention, this chapter considers a 
population level intervention which brings with it further complexities for evaluation, particularly in relation 
to attribution of effect.   
5.1 Study context  
Physical inactivity is associated with increased risk of a number of long-term health conditions, including 
coronary heart disease, diabetes and some cancers. Min-Lee et al estimated that the global attributable 
mortality associated with physical inactivity is comparable to smoking, accounting for around 6% of coronary 
heart disease cases, 7% of diabetes cases and 10% of breast and colon cancer cases (Min Lee et al 2012).  
Estimates from the UK suggest that the health impacts of physical inactivity cost the NHS over £7billion 
annually (PHE 2014).   
The benefits of pursuing an active lifestyle – even through moderate physical activity such as walking - are well 
documented (PHE 2014). However, it is important that the built environment is designed in a way that allows 
and even promotes physical activity. The World Health Organisation (WHO) has suggested that around 25% of 
people are insufficiently physical active and that environmental and social conditions contribute to this 
(Guthold et al 2018). A number of studies have examined the effectiveness of specific interventions designed 
to promote physical activity, including walking and cycling trails (Goodman et al 2014) and group activities 
(Burke et al 2006). Whilst many of these have suggested that they represent good value for money, they have 
also highlighted the methodological issues inherent in evaluating programmes of this type.   
In order to recognise the importance of physical activity, the NICE sought to develop guidance for public health 
stakeholders on the importance of environmental interventions to promote physical activity (National 
Institute for Health & Care Excellence 2018). The author was responsible for leading a programme of economic 
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research to inform the development of the guidance. Building on the methods employed in earlier studies, a 
multi-methods approach was adopted in an attempt to present the findings as clearly as possible to multiple 
stakeholders.   
5.2 Methods  
The study involved evidence synthesis from multiple sources to evaluate the effectiveness of cycling and 
walking trails intended to promote physical activity. Such trails may be developed with multiple objectives, 
including reducing traffic congestion, improving air quality and promoting physical health. For the purposes of 
the study two extreme cases were considered to determine how the costs of developing and maintaining trails 
should be attributed. In the first case, this assumed that all the costs were attributable to healthcare, which 
assumes that the primary intent of the trails is to improve the levels of physical activity. In the second example, 
this assumed that the objectives were primarily around improvements to the environment and that any health 
benefits would be secondary outcomes. In this case, only 5% of the cost was attributable to the health service 
decision maker.  
Three discrete analyses were undertaken to estimate the health benefits and combine these with the costs of 
the intervention.   
Cost utility analysis   
A simulation model was developed to quantify the long-term health benefits of increasing physical activity.  
The model was designed to predict the risk of developing coronary heart disease and stroke, based on the 
Framingham risk equations, and diabetes, based on the Diabetes Risk Score. Treatment costs for each 
condition were derived from published sources and then annualised. A time horizon of 10 years was adopted, 
reflecting the predictions generated by the risk equations above. The impact of long-term conditions was 
captured in terms of life-years lost as well as quality of life. All costs and outcomes were discounted at 
prevailing rates (3.5%) and presented in 2007 values. The resulting outcomes were presented in the form of a 
cost per QALY.   
Regression analysis  
The second method used large-scale panel data to estimate the health benefits of increasing physical activity. 
Health Survey for England data were used to correlate the relationship between physical activity (measured 
in 30-minute units) and self-reported health-related quality of life, measured by the EQ-5D. Regression 
analyses were used to control for possible confounding demographic variables (age, sex, ethnicity, 
employment/education status) as well as behavioural variables (smoking status, alcohol consumption, body 
mass index). The outputs estimate the incremental gain in health-related quality of life resulting from an 
increase of one unit of physical activity. This relationship was assumed to be linear – that it is 5 units of physical 
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activity would generate an increment in utility 5 times greater than a single unit of physical activity. These 
were then used to generate a cost per QALY by combining evidence on the effect of interventions on units of 
activity with the estimated cost of building and maintaining a trail. The two extreme values approach was 
adopted for costing purposes, assuming that 5% or 100% of the costs were attributable to health.    
Cost benefit analysis  
The third method was a review of cost-benefit analyses. Heterogeneity amongst the published research made 
direct comparisons and meta-analysis impossible. As such, an attempt was made to standardise the costs and 
benefits reported across the studies which necessitated a number of simplifying assumptions around the use 
of the cycle trail and the costs of maintenance. The output of the analysis was a ‘societal’ cost benefit ratio.    
5.3 Data  
The majority of the data used in the study were derived from published research identified in an accompanying 
systematic review conducted to inform the guideline development. Models for predicting long-term health 
outcomes were derived from well-established risk models, such as the Framingham equation. Cost data on 
the development, build and maintenance of cycling trails was scarce and in many cases not relevant to the UK. 
What data were available were used to inform the model although some significant simplifying assumptions 
were necessary.   
5.4 Outcomes  
Unsurprisingly the cost utility analyses suggest that access to a cycling trail results in improved health benefits, 
with QALYs gained estimated to be 0.042 and 0.227 over the 10-year time horizon. These occur as a result of 
a lower incidence of long-term conditions that are associated with physical inactivity.    
The second method estimated that QALY gains over a 30-year time horizon depending on the levels of 
participation in physical activity. Individuals who participated in one 30-minute session of physical activity per 
week were estimated to benefit from a 0.078 QALY gain. The relationship between participation and health 
benefits was assumed to be linear, so individuals who participated in 5 sessions per week were predicted to 
benefit from a 0.390 QALY gain. Cost per QALY calculations were based on a number of assumptions about 
the proportion of the cost of the intervention that was attributable to health. The cost per QALY remained 
below £10,000 in all scenarios. Assuming that 5% of the costs of the trail were attributed to the health budget 
then the cost per QALY fell below £500 in all cases.    
The final method attempted to standardise cost benefit ratios reported from previous studies. The resulting 
cost benefit ratio was estimated to be 1:11 – that is, for every £1 spent on the development and maintenance 
of the trail, society would accrue £11 in benefits. The majority of the reported benefit was accrued in the form 
of health benefits.    
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5.5 Strengths & weaknesses   
The paucity of detailed and accurate data, relevant to a UK setting, on the costs and benefits of environmental 
interventions to promote physical activity was the primary acknowledged challenge to the research. Whilst a 
number of studies reported overall levels of physical activity there was insufficient detail to establish whether 
this activity was ‘new’ physical activity amongst users who had previously been sedentary or substituted other 
activities that were already being conducted. This makes estimation of the societal impact very challenging – 
in the worst-case scenario, where the activity simply replaces another existing activity, the net societal benefit 
could be zero.   
The regression analysis assumed a linear relationship between physical activity and HRQOL whereby an 
individual who undertook 5 sessions of physical activity would receive five times the utility increment. 
Significant questions were raised over this at the time of the research and, in hindsight, this assumptions 
seems implausible. There is likely to be an incremental gain in utility in moving from a physically inactive state 
to a physically active state as a result of health benefits and the so-called process benefit (as explored in 
Chapter 7). Whilst this utility gain may further increase with increased levels of participation in exercise the 
relationship is unlikely to be linear and more will more likely display some degree of diminishing returns.    
Estimating the cost side of the equation is equally challenging. Environmental interventions often have 
multiple objectives including improving air quality, reducing traffic accidents and improving well-being.  The 
health benefits may be a primary or a secondary benefit. This made it necessary to make an arbitrary 
assumption about the proportion of the costs that should be attributable to health in a cost effectiveness 
analysis.   
The cost benefit analysis sought to address some of these challenges by taking a societal perspective. In doing 
so, it considers the cost to the economy as a whole – regardless of who pays – and the holistic benefits 
including the environment, well-being and physical health.  The results indicate a favourable cost benefit ratio.    
5.6 Critical appraisal  
The cost utility analysis was conducted as a default approach as this research was commissioned as a direct 
input to the NICE guideline on interventions to promote physical activity. Whilst the author and the research 
team had concerns about this method, it was felt that adopting the NICE reference case should be the default 
approach to maximise the relevance to the NICE decision-making committee. However, it is important to 
recognise that the intervention under consideration – environmental interventions to promote physical 
activity – have far-reaching benefits with health being only one of these. This was reflected in the findings of 
the cost utility analyses which indicated that the QALY gains over 10 years were modest and close to zero in 
some scenarios.    
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The alternative methods considered are believed to provide some additional insights that cannot be conveyed 
in the CUA ratio. Cost benefit seeks to quantify outcomes in monetary terms, rather than in natural units or 
QALYs. Whilst there are well documented challenges to defining monetary values for variables such as 
improved health or wellbeing, the outcomes generated are intrinsically appealing for many decision makers 
(McIntosh et al 2019). The methods adopted and resulting outcome (a cost benefit ratio) are expected to be 
more relevant to the majority of public sector decision makers, mirroring the methods that are commonly 
used in economic evaluations of transport, housing and environmental funding decisions. Whilst this may have 
some benefits over a QALY based ICER, it still suffers from being a composite endpoint which masks the 
absolute changes in the costs and benefits and where these are accrued.    
The research was commissioned to support the development of public health guidance by NICE so the 
application of cost benefit analysis was a deviation from standard economic evaluation methods that are 
recommended by NICE. The outcomes were influential in forming the basis of the recommendations that were 
included in the NICE guidance on physical activity and the environment. Furthermore, as one of the first public 
health economic evaluations commissioned by NICE, the methods are believed to have influenced the 
development of methodological guidelines which recognise the challenges of applying cost utility analysis and 
permit the use of alternative methods of cost benefit analysis. 
5.7 Chapter Summary  
This chapter seeks to further illustrate the potential shortcomings of applying cost utility analysis to population 
level public health programmes which are characterised by challenges in attributing effects and costs. Whilst 
the headline ICER was considered favourable, the use of a composite outcome masks some of the uncertainty 
in the derivation of the costs and outcomes, for example, assumptions about linearity in benefits associated 
with physical activity which seems like an unreasonable assumption.   
The cost benefit analysis presents an intrinsically accessible outcome for non-specialist stakeholders: for every 
£1 spent society gains £11 of benefit. However, this also suffers from being an aggregated, composite outcome 
which fails to present how the costs and benefits are accrued. A more granular presentation of these elements 
– in the form of a cost consequence – would help decision makers. The following chapter builds on the insights 








Chapter 6: The application of cost-benefit analysis to interventions to 
promote breastfeeding.  
Publication #5: Pokhrel S, Quigley MA, Fox-Rushby J, McCormick F, Williams A, Trueman P, Dodds R, 
Renfrew MJ. Potential economic impacts from improving breastfeeding rates in the UK. Arch Dis Child. 2015 
Apr;100(4):334-40.    
Available at:  https://adc.bmj.com/content/100/4/334 
 
Previous chapters have considered the application of cost utility analysis as the default for economic 
evaluation and introduced alternative methods, such as cost benefit analysis. This chapter will consider the 
application of cost benefit analysis to interventions designed to promote breastfeeding and introduces 
further granularity to the presentation of the findings, intended to address some of the shortcomings of the 
previous analyses.   
6.1 Study context  
There is an inverse association between the rate of economic development and breastfeeding, with very low 
rates now reported in many Western countries (Victora et al 2016). There appears to be a growing preference 
for breast-milk substitutes, driven partly by societal norms, the perception of increased convenience and 
promotion from the manufacturers. This is despite a significant body of evidence which points to the positive 
effects of breast-feeding, compared to the use of milk-substitutes, both for the mother and the child. A 
systematic review conducted alongside this economic evaluation, confirmed the results of earlier studies and 
illustrated that breast-feeding provides a lasting protective effect against a number of conditions, including 
gastro-intestinal infection, lower respiratory tract infections and acute otitis media in infants as well as breast 
cancer in mothers (Renfrew et al 2012). Although less robust, there are also statistical associations with a 
number of other conditions including cognitive development, obesity and sudden infant death.    
Estimates from the United States in 2007 report that increased breastfeeding rates could result in savings of 
over US$3billion, much of which relates to healthcare costs (Bartick & Reinhold 2010). Whilst similar studies 
have been conducted in Australia (Drane 1997) and the Netherlands (Buchner et al 2007), there was a dearth 
of high quality economic data relating to the UK. The current study was funded by UNICEF UK with the 
intention of generating robust economic data on the financial impact of breastfeeding in the UK. The study 
sought to estimate the costs and benefits associated with interventions to promote breastfeeding in the UK.   
6.2 Methods  
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A partial cost benefit framework was established to capture the costs and benefits of alternative feeding 
regimes. The association between feeding and outcomes was established through an accompanying 
systematic review. Four childhood conditions were considered in the analysis: gastro-intestinal illness, lower 
respiratory tract infections, acute otitis media and necrotising enterocolitis. Whilst there are statistical 
associations with other conditions, these four conditions were selected based on the strength of the data 
available. In addition to this, maternal breast cancer was also considered as an outcome.    
The costs of managing these conditions were derived from published sources. The time horizon for infant 
conditions was limited to one year whilst a lifetime horizon was adopted for the maternal outcomes. Only 
costs falling on the health service were considered – wider societal costs were excluded due to the challenges 
of quantifying these with any accuracy.   
Two separate approaches were adopted to quantify the impacts to children and mothers. Risk models, based 
on the evidence from the literature review, were used to estimate the incidence of each condition amongst a 
cohort of children. The lifetime risk of breast cancer amongst mothers was derived through a simple Markov 
model which applied the risks of developing cancer based on the whether they breastfed children or not.  
These analyses, when combined, generated an estimate of the costs associated with current levels of 
breastfeeding in the UK. Further analyses then sought to estimate the costs and benefits of interventions 
designed to increase the duration or exclusivity of breastfeeding.   
6.3 Results  
In the base-case analysis, the costs to the NHS of treating infant conditions occurring as a result of sub-optimal 
rates of breastfeeding was estimated to be ~£90million per year. The cost of treating incremental cases of 
breast cancer as a result of current rates of breastfeeding was estimated to be £960million.   
Unsurprisingly, interventions to increase the rates/duration/exclusivity of breastfeeding were found to reduce 
the incidence of infant and maternal conditions and, in turn, reduce the costs to the health service. Extending 
the proportion of women breastfeeding exclusively at one week to 4 months was estimated to result in a 
saving of around £11million per year. Increasing the rates of breastfeeding in neonatal units, arguably a more 
achievable target, had the potential to save ~£6million per year whilst doubling the proportion of women 
breastfeeding could result in savings of approximately ~£21million in the management of breast cancer. A net 
benefit calculation was also undertaken which valued any QALY gains resulting from improved breast cancer 
rates at £20,000 each; this resulted in a further benefit of £10million.    
The table below summarises the scenarios considered in the analysis and reports the potential savings in 
treating conditions included in the analysis for each policy scenario. The first row reports the estimate of the 
average treatment cost per person of each condition considered based on current levels of breastfeeding.   
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Table 6.1: Estimated average costs per individual of treating identified diseases and potential cost savings 
associated with increased breastfeeding rates in the UK (£2009–2010 prices). (Reproduced from Pokhrel et 
al 2015).   
   
  
The table highlights the need for multi-component interventions if changes in breastfeeding behaviour are to 
address both childhood and maternal conditions.   
6.4 Strengths & weaknesses  
Despite the original nature of the research there are a number of limitations with the methodology, some of 
which were recognised at the time of the study. Given the paucity and uncertainty of data, it was only possible 
to include a small number of conditions which are associated with breastfeeding. The accompanying 
systematic review suggests that breastfeeding may impact the incidence of a range of other conditions, 
including cognitive development and behavioural outcomes (Quigley 2012). As a result of this, the resulting 
estimates might be considered under-estimates of the true financial impact.    
It should also be noted that the evaluation failed to incorporate the costs of interventions. The study estimated 
the potential savings that might occur as a result of hypothetical improvements in breast feeding rates and 
duration. However, no estimate of the costs of achieving these rates were considered in the publication.  
Further consideration was given to this in the full report provided to the study sponsor (Renfrew et al 2012).  
 
6.5 Critical appraisal   
This was recognised as an important contribution to the evidence base on breastfeeding and sought to provide 
a more robust economic rationale for investing in interventions to improve breastfeeding rates. As the first 
UK study to do so, the outcomes garnered significant attention from the press (The Guardian n.d.), broadcast 
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media and decision makers and continue to be referenced in policy recommendations in England (Public 
Health England n.d.) and overseas (Davanzo et al 2015). 
Building on the previous case studies considered in this thesis a number of methodological improvements 
were incorporated into the design to improve the relevance to stakeholders. Firstly, a narrow perspective was 
consciously adopted, which meant any potential financial benefits accrued would be directly applicable to the 
health service decision maker, who was deemed to be the major funder of the intervention. Secondly, the 
short-term cost impacts (acute childhood infections) were reported in a disaggregated way from the long-
term cost impacts to the mother. Again, this improves the relevance by identifying short-term costs which may 
be improved as a result of investment in public health interventions thereby allowing the decision maker to 
determine a net financial benefit. Finally, outcomes were reported in disaggregated, natural units wherever 
possible (for example number of cases avoided/100,000 popn). Where this was not possible, an estimate of 
the direction of the effect was included in an attempt to capture the full range of benefits, even where these 
could not be quantified.   
The core analysis is relatively easy to interpret: breastfeeding is associated with a reduced risk of a number of 
childhood and maternal conditions. Therefore, improving breastfeeding rates will reduce the incidence, and 
associated costs, of these conditions. However, the analysis does become more complex as a result of the 
number of scenarios that are modelled. It was necessary to model scenarios that:   
1. Affect the rate of any breast-feeding;  
2. Affect the rate of breast-feeding prior to discharge from the neonatal unit;   
3. Affect the rate of exclusive breastfeeding;   
4. Affect the duration of any breastfeeding.   
The result was that 11 separate hypothetical interventions were modelled in the analysis resulting in a 
multitude of outcomes.    
A clearer solution might have been to identify a smaller number of ‘most likely’ scenarios that could be 
referenced to published evaluations of interventions. This could have provided a clearer indication of the 
feasible savings that might be achieved and furthermore, allowed for an estimate of the cost of the 
intervention to be included thereby generating a better comparison of the costs and benefits.    
The approach adopted in this analysis does offer some guidance to how future evaluations of public health 
interventions might be presented to increase their impact. The logic framework used in this analysis was 
intended to firstly illustrate the scale of the problem to the health service (and society more generally) before 
considering how this might be improved. This is a critical step in justifying investment in public health. In 
previous analyses, the focus was on the incremental improvements in outcomes but there was limited 
reporting of the financial and human burden associated with current behaviours. For many public health 
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interventions, this burden might be considered avoidable where it results from behavioural trends or 
decisions, such as the choice of whether to breastfeed or be physically active.  Illustrating and quantifying the 
‘do-nothing’ scenario is seen as an important step in engaging decision makers prior to evaluating 
interventions.   
The methods adopted are believed to provide a pragmatic approach that should meet the needs of multiple 
decision makers. By starting with a disaggregated CCA, decision makers can easily understand the costs and 
benefits of the intervention, whilst CUA and CBA elements provide QALY gains and an estimate of net benefit 
for decision makers more used to these outcomes. The first step of presenting the outcomes in a disaggregated 
fashion before moving to composite ratio outcomes is an important one in improving transparency.   
6.6 Chapter summary   
This chapter explores an alternative approach to the economic evaluation of public health interventions, by 
adopting a quasi-cost benefit analysis with outcomes also presented in a disaggregated cost consequence 
analysis. The cost consequence analysis also allows for directional reporting of a wider range of impacts even 
where these cannot be adequately quantified in monetary terms or health benefits. Complexity was added 
due to the number of scenarios modelled and in hindsight this could have been further improved. The next 
chapter will continue to contrast the use of alternative methods of economic evaluation, concluding with a 
cost consequence analysis.    




Chapter 7:  The application of economic evaluation to exercise referral 
schemes to promote physical activity.   
  
This chapter comprises the final case study, applying economic evaluation to exercise referral schemes. The 
research was commissioned by the NIHR HTA programme and allowed sufficient scope to explore the 
application of multiple methods of economic evaluation, building on the lessons learned from the studies 
presented in earlier chapters. These alternative methods were applied in an attempt to make the results as 
accessible as possible to decision makers and provide an illustration of alternative approaches to economic 
evaluation for other researchers working in the field of public health. The chapter includes 4 separate papers 
produced as part of the research programme.   
7.1 Study context  
Physical activity plays a critical role in the prevention and management of many medical conditions through 
multiple biological and psychological mechanisms. There is an obvious relationship between physical activity 
and weight gain which in turn is associated with the risk of long-term conditions, such as coronary heart 
disease and diabetes mellitus (Department of Health 2004). In addition to the biologic effects, physical activity 
has also been shown to be correlated to mental health (Stephens 1988), depression (Rebar et al 2015) and 
even dementia (Blondell et al 2014).   
Government endorsed guidelines recommend that adults should undertake at least 30-minutes of exercise of 
moderate intensity at least five times a week (Department of Health 2004). However, public health data 
suggest that many people fail to achieve this level of activity due to increasingly sedentary life-styles and an 
over-reliance on transport (Craig et al 2009).    
Chapter 5 considered public health programmes designed to ‘nudge’ people to a more active lifestyle by 
developing built environments more conducive to exercise. An alternative approach to promoting physical 
activity is a more targeted, individualised intervention focussed in individuals who are recognised as physically 
inactive to an extent that it could harm their long-term health. Exercise referral schemes (ERS) were first 
introduced into general practice around 1990 with guidelines being introduced for best practice at a later 
stage (British Heart Foundation National Centre n.d.). Under these schemes, individuals with a recognised 
cardiac risk factor are prescribed an exercise programme, typically provided by a third-party service, such as a 
sport centre or gym. The service provider then works with the individual to define a programme of exercise 
and monitor their adherence to the programme.   
A number of previous studies have sought to establish whether exercise referral schemes can increase physical 
activity levels in individuals who were previously sedentary (Morgan 2005) (Williams et al 2007). These studies 
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considered only short-term outcomes (physical activity) and did not consider the impacts on health outcomes 
nor did they consider the cost effectiveness of such interventions.    
This chapter considers four publications which were developed as part of a NIHR HTA programme of research.  
The research was commissioned to address a specific evidence gap identified by the NICE guidance on physical 
activity (National Institute for Health Care & Excellence 2006) which questioned the clinical and economic 
value of exercise referral schemes.    
  
Publication #6: Pavey TG, Taylor AH, Fox KR, Hillsdon M, Anokye N, Campbell JL, Foster C, Green C, 
Moxham T, Mutrie N, Searle J, Trueman P, Taylor RS. Effect of exercise referral schemes in primary care on 
physical activity and improving health outcomes: systematic review and meta-analysis. BMJ. 2011 Nov 4;343.   
Available at: https://www.bmj.com/content/343/bmj.d6462 
 
A systematic review and meta-analysis of exercise referral schemes was conducted as a foundation for the 
programme of research (Pavey et al 2011). This study sought to update previously conducted systematic 
reviews and also address some of their limitations, notably quantifying the impact of these schemes on health 
outcomes and providing data to support a cost effectiveness analysis.    
7.2 Methods  
A comprehensive search strategy was defined to capture all relevant studies on exercise referral schemes.  
Searches were limited to English language and 1990 onwards, which was deemed to be the time at which such 
schemes were introduced into the NHS. The search sought to identify studies based in primary care settings 
to improve their relevance to the overall programme objectives. Only comparative studies were included in 
the analysis, although in recognition of the challenges of randomisation and blinding in studies of public health 
interventions, non-randomised study designs were included, such as cluster studies. PICO criteria were 
developed with critical components being:   
Population: individuals with and without a prior medical diagnosis meaning individuals considered ‘at-risk’ 
would be included;   
Intervention: comprises a) referral from a primary care professional to a third party provider; b) physical 
activity programme tailored to individual needs, as opposed to a population intervention; c) initial assessment 
and monitoring throughout the programme.   
Comparator: any control, typically no intervention or usual care comprising lifestyle and behavioural advice;   
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Outcomes: physical activity, self-reported or objectively measured, but also clinical outcomes such as the 
incidence of coronary heart disease and diabetes mellitus, health related quality of life and adverse events.   
7.3 Data  
A significant number of relevant articles were reviewed but only 8 studies were considered suitable for 
inclusion. The majority of studies were excluded on the basis of limited information on how individuals were 
referred to physical activity programmes, causes for the referral and a lack of details of the provider of the 
programme. Of the 8 studies included, 6 were completed, published studies and 2 were study protocols, one 
of which was associated with an unpublished study report made available by the investigators.  The studies 
included 5190 participants, with six of the eight included studies being conducted in the UK, one in Denmark 
and one in Spain. Study duration was between 2-12 months and 6 of the 8 studies compared exercise referral 
schemes with usual care/no-intervention whilst two studies compared exercise referral with alternative 
physical activity interventions, such as walking programmes.   
7.4 Outcomes  
Physical activity outcomes were the most consistently reported outcome across the studies included, typically 
reported as the proportion of individuals achieving the recommended levels of activity of 90-150 minutes of 
activity per week. The pooled data identified a 16% increase in the relative risk of achieving this outcome 
amongst individuals who participated in exercise referral schemes compared to usual care at 6-12-month 
follow-up. No differences were found in outcomes between exercise referral schemes and alternative 
interventions designed to promote physical activity whilst the addition of a behavioural change intervention 
to the exercise referral scheme had a detrimental effect of physical activity levels. The Forrest plot below 
summarises these findings. Notably, in the comparison of exercise referral schemes vs usual care the 
confidence intervals of the four studies considered all cross 1. An adjusted analysis considered only those 
participants that agreed to randomisation (a per protocol analysis compared to the ITT analysis of the baseline) 
resulted in a further weakening of the result. The comparison of exercise referral schemes with other 
interventions to promote physical activity show even greater uncertainty over whether there is any beneficial 




Figure 7.1: Meta-analysis of patients achieving 90-150 minutes of physical activity of at least moderate 
intensity per week, using denominators as reported by study authors and denominators adjusted to all 
randomised groups (reproduced from Pavey et al 2011).   
 
Of the studies that considered psychological well-being there were significant improvements in physical 
selfworth and perceptions of physical condition and physical health in the exercise referral scheme 
participants. Single studies also showed improvements in depression scores.    
The impact of exercise referral schemes on HRQOL was difficult to interpret due to different measures and 
follow-up periods. One study failed to show any difference on the SF-36 whilst a second study reported a 
significant improvement amongst exercise referral participants using the EQ-5D measure.    
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Overall, the study concluded that there was ‘weak’ evidence of a short-term increase in physical activity to 
meet recommended levels and a reduction in levels of depression in individuals that participated in exercise 
referral schemes compared to individuals managed through usual care. However, there was no statistically 
significant difference in clinical outcomes, such as blood pressure, obesity and glycaemic control.  
Furthermore, exercise referral schemes were not found to offer incremental benefits above other, less 
structured physical activity interventions, such as walking programmes.   
7.5 Strengths & weaknesses  
Extensive efforts were made to screen evidence to ensure that only studies that considered the specific 
intervention were included in the analysis which generated a robust systematic review. The downside of such 
a narrow definition is that there was significant attrition in the literature screening process, excluding a 
number of potentially relevant studies due to lack of detail on referral pathways and interventions, resulting 
in a small number of studies being included in the review.   
A further limitation of the study was the heterogeneity amongst the studies and inconsistency in the reporting 
of outcomes. The result was that only measures of physical activity, physical fitness and clinical outcomes 
levels could be meaningfully pooled in a meta-analysis. Even where pooling was possible, caution should be 
taken in interpreting the pooled results due to heterogeneity amongst studies. Differences in outcomes 
measures meant that it was inappropriate to pool other outcomes such as psychological wellbeing and HRQOL 
meaning findings were often based on individual studies.    
7.6 Critical appraisal  
This programme of research was intended to address a very specific question raised by NICE in guidance on 
physical activity which suggested that there was insufficient evidence to support the widespread adoption of 
exercise referral schemes and recommended that such schemes should be restricted to controlled trials. 
Despite this guidance, it was recognised that exercise referral continued to be prescribed widely in primary 
care outside of controlled trials and there was a pressing need to determine whether such schemes are 
justified. Although previous systematic reviews had been conducted, the study included a number or more 
recent studies and also expanded the range of outcome measures considered to provide a more relevant 
assessment of the impact on health.    
Somewhat controversially, the study concluded that the case for continued investment in exercise referral 
schemes should be reviewed and that the limited effect identified in the study may even make a case for 
disinvestment. This is a somewhat unique outcome for evaluations of public health interventions which 
typically find that due to the low-per capita cost of the intervention, even a modest effect results in a cost 
effective outcome, as reported in the Owen paper (Owen et al 2018). In this case, a robust assessment of 
effectiveness found little evidence to suggest that individualised interventions resulted in any meaningful 
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health impact. The best case is that the use of such interventions should remain restricted to controlled trial 
environments to provide further evidence and address some of the gaps and inconsistencies in the evidence 
identified in the current study.    
The findings of this study were directly applicable to NICE guidance on physical activity and were also shared 
with public health professionals in the Department of Health to inform the development of future policy.    
  
Publication #7: Anokye NA, Trueman P, Green C, Pavey T, Hillsdon M, Taylor RS.  The cost effectiveness of 
exercise referral schemes.  BMC Public Health2011; 11:954. 
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Building on the systematic review and meta-analysis reported above, an economic evaluation of exercise 
referral schemes was conducted (Anokye et al 2011). This sought to answer the question of whether referrals 
to ERS represent value for money in individuals with a pre-existing health condition, such as coronary heart 
disease or depression. Given the uncertainty over the effectiveness of such interventions, their cost 
effectiveness becomes even more important to decision makers concerned with making the best use of 
available NHS resources.   
The systematic review identified 4 previous studies that had sought to estimate the cost effectiveness of ERS 
programmes. Of these, three were economic evaluations alongside clinical trials (Gusi et al 2008) (Isaacs et al 
2007) (Stevens et al 1998) and one was a modelling study based on evidence synthesis (National Institute for 
Health & Care Excellence 2006). In all cases, these had suggested that such interventions are cost effective 
although there were limitations in terms of the data on efficacy and the use of a sedentary but healthy 
population. The latter is a particular problem as exercise referral is unlikely to be prescribed by the NHS for 
healthy individuals and is more typically targeted towards individuals who have a pre-existing condition.    
7.7 Methods  
A simple, decision analytic model was developed which considered the impact of physical activity on the 
development of coronary heart disease, stroke and diabetes. The model structure and many of the inputs 
were derived from the model used to evaluate trails discussed in chapter 4. These conditions were chosen due 
to the availability of robust data on their correlation with physical activity. The model considers a cohort of 
sedentary individuals and the effect of exposure to an exercise referral programme on their physical activity 
levels. Activity was considered to be a binary endpoint – active or non-active – based on whether an individual 
meets guideline recommendations of 90-150 minutes of at least moderate physical activity per week.   
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Evidence on the effectiveness of ERS programmes was derived directly from the systematic review which 
provided an estimate of the relative risk of moving from a sedentary state to an active state. Where individuals 
became active they were assumed to remain active for a sufficient time to provide long-term health benefits, 
a so-called ‘fully engaged’ population. Evidence on the relationship between physical activity and long-term 
outcomes was derived from the systematic review and Health Survey for England data.    
The costs of the ERS intervention were derived from a previous publication whilst treatment costs for long-
term conditions were derived from previous publications. Annual costs were estimated for coronary heart 
disease and diabetes as long-term, chronic conditions, whilst the cost of stroke was considered as a one-off 
event. A cost utility analysis approach was adopted which reported outcomes in the form of incremental cost 
per quality adjusted life year (ICER).    
7.8 Outcomes/Results  
The base-case analysis generated an ICER of £20,876. This was based on an incremental life-time cost £170 
per person in the ERS group and an incremental QALY gain of 0.008. The ICER might be considered to be 
‘borderline’ cost effective according to criteria applied by NICE. The point estimate of the ICER masks small 
changes in both lifetime costs and QALY gains. The marginal QALY gain – 0.008 over a lifetime – is unsurprising 
given the limited effect of the interventions identified in the systematic review. In sensitivity analyses, which 
explored the impact of a range of scenarios based on the systematic review, the incremental QALY gain ranged 
from -0.01 (that is, worse outcomes than usual care) to 0.015. The cost of the intervention was also varied in 
sensitivity analyses and resulted in a range of values from ERS being dominated by usual care (more costly 
with inferior outcomes) to an ICER as low as £679.   
Probabilistic sensitivity analyses attempted to address the uncertainty, estimating that there is a 51% chance 
of ERS being cost effective with a threshold of £20,000 per QALY and a 88% chance of it being cost effective 
at a £30,000 level. Of course, the probabilistic analysis reflects the assumptions made about the input 
parameters which may be subject to significant uncertainty. The meta-analysis produced an estimate of 
effectiveness of 1.16 in favour of ERS, with a range of 1.03 to 1.30. Estimates of effectiveness derived from 
individual studies considered in the meta-analysis included values below 1, indicating no positive effect of ERS.    
Sub-group analyses considered the cost effectiveness of ERS when targeted at individuals with pre-existing 
longterm conditions. In these cases, the ICER decreased from the baseline of approximately £20,000 per QALY 
to between £8,000 - £14,000 per QALY.    
7.9 Strengths & Weaknesses  
Challenges associated with the model include a) limitations in the data on the effectiveness of ERS derived 
from the systematic review and b) the adoption of a lifetime model based on short-term effectiveness data.  
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The limitations of the effectiveness data are discussed in the previous section which appraised the systematic 
review and noted significant uncertainty and a weak effect size. The decision to adopt a lifetime model was 
taken to capture the impact of physical activity on long-term conditions, namely coronary heart disease and 
diabetes. Whilst there is a robust relationship between physical activity and these conditions, this time horizon 
demanded that some fairly gross assumptions were made about the long-term effectiveness of ERS. The model 
assumes that any individual who moves from a sedentary to an active status remains active for a sufficient 
period to affect their risk of developing long-term conditions. Given that the majority of the data from the 
systematic review reported outcomes between 6-12 months and provided little in the way of evidence on 
adherence to ERS programmes, this assumption is open to significant scrutiny. A further issue arose in the 
analysis of subgroups with underlying conditions that elevate the risk of long-term health conditions. Whilst 
these groups are typical of the population prescribed ERS and therefore should be the group considered by 
the model, there was a dearth of detail in the underlying literature to determine whether the effectiveness of 
ERS differs in these groups. As such, any outcomes relating to these groups should be considered hypothetical 
and treated with significant caution.   
On the strengths side it should be noted that there are some areas where the model adopted a cautious 
approach, including limiting the number of long-term conditions to three and excluding any process benefits 
from physical activity which might benefit mental health and well-being.    
7.10 Critical appraisal  
This study sought to address a critically important question that had been raised by previous NICE guidance, 
namely are ERS cost effective. As an adjunct to the systematic review this was intended to provide clear 
guidance to decision makers on whether investment in ERS should be expanded or discontinued.    
Unfortunately, the study was undermined by the quality of the effectiveness data identified in the systematic 
review.  Having found a very modest positive effect of ERS which was associated with considerable uncertainty 
it was somewhat unsurprising that ERS were also found to be of questionable economic value. As with previous 
examples reported herein, the results identified marginal – some would say almost negligible – differences in 
lifetime costs and outcomes associated with ERS which make the ICER unstable. This was illustrated in the 
discussion which showed that in the base case analysis the QALY change of 0.008 resulted in a cost 
effectiveness ratio which might be considered borderline acceptable. Changing the QALY gain by one 
hundredth to 0.007 would shift the ICER to being unacceptable. Again, this illustrates the dangers inherent in 
a composite ratio as an outcome measure. On face value, decision makers might take the ~£20,000 per QALY 
as a favourable basis on which to make investment decisions. Indeed, this was one of the evaluations 
considered ‘highly cost effective’ by Owen at el in their summary paper. However, disaggregating the ratio 
provides a clearer picture and helps understand the absolute impact of the intervention to the patient. In 
order to better comprehend the uncertainty it might be worth asking how an individual would describe the 
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difference between the base case QALY gain of 0.008 over a lifetime and a QALY gain of, say 0.005. The reality 
is that such small changes in outcomes are likely to be difficult to comprehend for the majority of people and 
highlight the peril of the ICER.    
It should be noted that the study considers exercise referral as an input to improved outcomes. No attempt 
was made to capture the process benefits that might result from participation in physical activity.  
Incorporating benefits to mental well-being may improve the cost effectiveness ratio. The next study 
conducted as part of this research sought to address this issue and determine whether this would have a 
favourable impact on the outcomes.   
  
Publication #8: Anokye NA, Trueman P, Green C, Pavey T, Taylor RS. Physical Activity and health related 
quality of life. BMC Public Health 2012; 12:624.  
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It is widely recognised that the act of engaging in physical activity may provide immediate, process benefits 
in terms of improved mental well-being, as well as longer term health benefits. Indeed,  there are studies 
which have sought to assess whether participation in exercise programmes  can improve mental health and 
wellbeing (Gusi et al 2008). The current study sought to use panel data to establish the correlation between 
physical activity levels and health related quality of life (Anokye et al 2012) in order to address the gap 
recognised in the previous study.  
The assessment of both physical activity and health related quality of life are both subjective to some extent.  
Quality of life can be captured by using standardised questionnaires which provide some degree of confidence 
about what is being measured and reported by individuals. Whilst physical activity levels can be measured 
objectively, for example, through the use of accelerometers, in many cases data are self-reported and as such, 
are subject to some degree of reporting bias. This study sought to include both subjective and objective 
measures of physical activity.   
7.11 Methods  
Panel data from the Health Survey for England were used to identify health related quality of life data and 
information on physical activity levels. The Health Survey for England includes a representative cross section 
of the English population and explores different health and lifestyle behaviours in each survey. For the 
purposes of our study, the 2008 survey results were used which includes a sample of over 9,000 households 
with over 15,000 adults and 7,000 children. The focus of the 2008 survey was physical activity and fitness and 
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included subjective measurement of physical activity, through self-reporting, and objective measures through 
the use of accelerometers. Physical activity was considered to include a walking, housework, occupational 
activity and sports & exercise. For the purposes of our study, it was important to determine whether the types 
of physical activity used in exercise referral programmes would lead to an improvement in health-related 
quality of life so the definition of physical activity was limited to walking and sports & exercise. Physical activity 
was treated as a binary variable with individuals who achieved 90 of more minutes per week being classed as 
‘active’ and individuals with less than 90 minutes per week of activity being classed as ‘inactive’.   
The objective assessment of activity was measured in a sub-sample of participants who agreed to use the 
accelerometers over a 7-day period for a minimum of 10 hours per day. Participants also completed a diary to 
detail their activities.   
Health related quality of life (HRQOL) was measured through use of the EQ-5D.  Scores were translated into 
utility scores using the tariff which generates a score between 0 (death) and 1 (full health).    
Regression models were developed to determine the relationship between HRQOL and physical activity levels.  
Dummy variables were defined for missing data whilst methods were put in place to handle censoring of 
HRQOL data (limiting it to a maximum of 1 according to the utility score) and co-variates linked to HRQOL such 
as sociodemographic variables).    
Four regression models were run to consider the different definitions of physical activity:   
Model 1 – walking only  
Model 2 – sport & exercise  
Model 3 – objective assessment through accelerometer data  
Model 4 – subjective assessment of physical activity.   
In each case, two versions of the model were run, one with missing data excluded and one with imputed 
missing data values.   
7.12 Results  
The proportion of individuals reported as physically active was 12% for both sports & exercise and objective 
measurement; 16% for walking and 44% for subjective measurement. Whilst subjective measurement includes 
a broader definition of physical activity, incorporating housework and occupational activities, this does suggest 
that individuals over-estimate their levels of physical activity. The mean utility score was 0.86.  The majority 
of individuals were considered to be over-weight (34%) or obese (26%); 22% self-reported as smokers and 85% 
consumed alcohol.   
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Individuals who self-reported as physically active were associated with improved health related QOL scores.  
This positive association was consistent across all definitions of physical activity, including walking, sports and 
exercise and objective outcomes. Self-reported walking and sports & exercise were associated with a modest 
impact on HRQOL, possibly reflecting the propensity for over-reporting of subjective measures of activity. The 
regression analyses identified a greater effect of objective measures of physical activity than subjective, 
selfreported measures (co-efficient of 0.072 vs 0.047). This was confirmed through the descriptive statistics 
that reported a marginally higher self-reported HRQOL amongst objectively measured physically active 
individuals compared to self-reporting (0.918 vs 0.916).   
7.13 Strengths & weaknesses  
The study was based on a cross-sectional cohort of individuals reporting their physical activity and HRQOL 
which creates a number of limitations. Whilst cross-sectional data allow for associations to be determined, it 
is not possible to determine causality. As such, it is impossible to state whether HRQOL is improved as a result 
of physical activity or there is a higher likelihood of physical activity in individuals with higher HRQOL. As a 
cross sectional study, it is also impossible to determine whether the increased HRQOL is sustained over a 
period of time as the analysis is based on point estimates at the time of the survey. Finally, as with all cross-
sectional studies, there may be limitations on generalising the results beyond the population in the sample.  
In this case, our sample comprised individuals aged 40-60 and whilst some efforts were made to control for 
confounding variables in the comparisons, there may still be characteristics of the study population which 
prevent widespread generalisation of the results.   
On the positive side, this is one of the few studies to attempt to quantify the process benefits of taking part in 
physical activity which have been overlooked in previous studies, including those reported herein. 
Furthermore, the study attempted to determine whether objective or subjective reporting forms the most 
appropriate basis for such an evaluation and identified that subjective reporting may be open to reporting 
bias. This is an important contribution to the evidence on this issue, particularly given the challenges 
associated with extrapolating long-term health benefits from short-term measures of participation in physical 
activity.   
7.14 Critical appraisal  
This study was intended to provide further insights into the benefits of taking part in physical activity and act 
as a supplement to the earlier study which considered physical activity as an input to long-term health. The 
relationships between physical activity, mental wellbeing and the downstream association with longer-term 
health benefits are complicated and poorly understood. Whilst it is widely accepted that physical activity is 
associated with improved well-being there remains difficulty in establishing the nature of this relationship.   
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As a contribution to decision making these data further develop the initial cost utility analysis presented earlier 
in this section. The cost utility analysis found ERS to be of questionable effectiveness when viewing it as a 
determinant of long-term conditions. Adding in the short-term HRQOL benefits provides a slightly more 
favourable perspective and a more holistic view of the potential benefits of ERS programmes. These benefits 
could be added into the cost utility analysis to supplement the health benefits identified earlier or alternatively 
could be presented separately as a cost consequence analysis which reports both short- and long-term health 
benefits. Given the uncertainty in many of the underlying data points and the difficulty in extrapolating these 
to long-term impacts on life expectancy, cost utility analysis runs the risk of producing spuriously accurate 
outcomes. In light of this, the decision was made to undertake a cost consequence analysis to complement 
the CUA and provide a more granular view of the costs and outcomes which is presented in the next section.   
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The final article in the programme of work examining exercise referral schemes sought to build on the initial 
research methods and test a more pragmatic approach to economic evaluation (Trueman & Anokye 2013).  
This was intended to recognise some of the shortcomings of the previous methods highlighted in the critiques 
presented above. The study sought to provide both a cost utility analysis and a cost consequence analysis of 
exercise referral schemes based on data derived from the systematic review and modelling exercises. CUA 
might be considered a composite outcomes that brings together costs with clinical outcomes and quality of 
life in the form of a ratio, namely the incremental cost per QALY. As highlighted throughout this thesis, the use 
of such a composite ratio can be misleading as it may disguise marginal, even negligible, differences in 
outcomes or may be subject to significant uncertainty. In contrast, CCA presents a disaggregated outcome 
with costs and impacts reported separately and typically in ‘natural units’, such as the number of cases of 
heart disease. In doing so, it can provide a more granular view of the programme impacts and address the 
needs of stakeholders with different perspectives.   
7.15 Methods  
The decision-analytic model described previously was adopted for the cost utility analysis. A decision analytic 
model was preferred to a Markov model or more sophisticated simulation model on the basis that it addresses 
the decision problem – namely what impact access to an ERS programme would have on individuals – in the 
simplest methodological approach. Whilst a more sophisticated simulation model could have been adopted 
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prior experience suggests that in the absence of robust data these often require gross assumptions. Inputs to 
the model were derived from the systematic review reported earlier in the chapter. Evidence on the 
effectiveness of ERS programmes was derived from the systematic review and reported in the form of a 
relative risk of becoming active compared to individuals who did not participate in a referral programme. The 
reported relative risk was 1.16 although it should be noted the lower confidence interval was below 1, 
indicating that there is a possibility that ERS do not change the incidence of physical activity participation. 
Health outcomes considered were the same as the original modelling exercise, namely coronary heart disease, 
diabetes and stroke. Costs of ERS were derived from a published study (Isaacs et al 2007) as per the original 
model.    
For the CCA, the outcomes were reported in natural units, such as cases of CHD. For the purposes of the CCA, 
other morbidities associated with physical activity were also included in the analysis. However, given that the 
magnitude of effect between physical activity and these conditions was poorly defined (which is why they 
were excluded from the original modelling exercise) it was only possible to give an indication of the direction 
of change that might be expected from increased participation in physical activity.    
7.16 Outcomes  
As previously reported, the estimated ICER of ERS programmes was £20,876, based on an incremental lifetime 
cost of £170 and an incremental benefit of 0.008 QALYs. Given the small increment to lifetime benefits (0.008 
QALYs), the ICER is very sensitive to any changes in assumptions about the effectiveness of ERS and the cost 
per participant. In sensitivity analyses, the ICER ranged from dominant to cost ineffective (>£30,000 per QALY).   
The CCA outcomes were reported in a tabular format for ease of use. Outcomes were presented for an 
illustrative cohort of 100,000 people who might be considered suitable for ERS. The cost of ERS provision for 
this cohort was estimated to be ~£22M to the prescriber and a further ~£12M to the participants, generating 
a societal cost of around £33M in total.   
The impact on outcomes that can be quantified were reported first and indicated that offering ERS to this 
cohort of individuals would result in:   
• An additional 3,900 individuals becoming physically active;   
• 51 cases of CHD avoided;   
• 16 cases of stroke avoided;   
• 86 cases of diabetes avoided.   
The CCA also indicates that there may be beneficial, if unquantified, health benefits in terms of the incidence 
of cancer, improvements in hypertension and improvements in a number of musculoskeletal conditions 
(osteoporosis, osteoarthritis, rheumatoid arthritis, low back pain and falls prevention). Whilst these 
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improvements were not quantified, there may be some lasting effects associated with them, such as a risk of 
reduction in falls which may reduce the need for long-term care and even reduce mortality. The CCA also 
highlighted some of the benefits in terms of mental health outcomes that were identified in the previous 
study. Finally, the CCA also indicated that ERS programmes should reduce absenteeism at work which may 
benefit both participants and their employers.    
7.17 Strengths & Weaknesses  
The CUA reported in this analysis is identical to the one reported earlier in the chapter and is subject to the 
same limitations, notably, a) limitations on the range of conditions affected by physical activity that were 
included in the model; b) the estimate of effect size for ERS being close to zero and c) the resulting instability 
in the ICER.   
The CCA approach sought to address some of these points by a) considering a broader range of impacts of 
physical activity and b) reporting outcomes in a disaggregated fashion thereby overcoming the weaknesses of 
using a ratio with a small denominator. It should be acknowledged that the inclusion of more physical activity 
related outcomes meant that in many cases it was only possible to report a directional impact rather than an 
estimate of effect. However, this was intended to provide a more rounded picture for decision makers by 
illustrating how far-reaching the effects could be.    
7.18 Critical appraisal  
This final study of the ERS programme benefited from the extensive research already conducted on the 
effectiveness of ERS programmes and the cost utility analysis. The study sought to acknowledge some of the 
recognised weaknesses in the application of CUA to this intervention and address these through the 
application of an alternative methodology, namely CCA. In my view, the CCA provides a much more granular 
picture of the impact of ERS programmes and attempts to provide a more holistic view of the impact.  
Furthermore, the use of natural units seems more intrinsically appealing to decision makers from both health 
and non-health sectors by indicating where costs and benefits are accrued. Compared to the original CUA 
which suggested that ERS provide an incremental benefit in QALYs at three decimal places per participant over 
their lifetime, the CCA estimated that this would translate to over 150 fewer episodes of CHD, diabetes of 
stroke. Further benefits are expected to be accrued in the form of improvements in mental health and 
musculoskeletal disease, although these could not be quantified, as well as improvements in absenteeism.  
This dashboard of costs of outcomes is intrinsically easier to comprehend that the composite ratio of the ICER 
and provides much more colour on the findings. The one remaining challenge which is common to both the 
CUA and CCA approach is the issue of the time horizon and when events might occur. The majority of public 
body decision makers operate with shortterm, often annual, budgets, which need to be balanced. Whilst the 
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CCA provides a more granular view of the outputs it still falls short of being able to illustrate when any benefits 
may materialise and how these might impact short-term budgets.   
This final study is one of the few examples of a comparison between alternative methods of economic 
evaluation. Whilst it was not possible to continue the research to explore decision makers attitudes to these 
different approaches, it seems intrinsically likely that the transparency and ease of interpretation of the CCA 
are likely to appeal to a broader range of decision makers than the narrowly defined CUA which relies on an 
indepth understanding of economic concepts and an ability to interpret ratios effectively.     
7.19 Chapter Summary  
The four studies relating to exercise referral schemes presented in this chapter are intended to provide an 
illustration of how the author’s understanding of economic evaluation of public health interventions has 
developed over time and, in particular, how outputs can be presented in a granular fashion to improve their 
accessibility. The application of cost consequence analysis is considered to provide the most widely accessible 
format for evaluation, providing a granular view of the costs and benefits and indicating where these are 
accrued.    
The next chapter will provide a summary of the author’s learnings from these studies and some broad guidance 
for future evaluations of public health interventions.   
  




Chapter 8: Summary, recommendations & conclusions  
 
8.1 Thesis summary   
To recap, the stated objectives of this thesis were as follows:   
• Consider the challenges associated with the economic evaluation of public health interventions;   
• Critically assess the application of economic evaluation methods to public health through a series of 
case studies based on the author’s published outputs;   
• Develop evidence-based recommendations for how future evaluations of public health interventions 
might build on the critique presented.    
The raison-d’etre of economic evaluation in healthcare is to address the challenges of scarcity and choice.  
Health service resources (budgets, staff, facilities) are limited whilst demands for health services continue to 
grow, driven by demographic trends, changes in patterns of morbidity and increasing expectations about what 
constitutes a medical need. As a result of this, decision makers need to make choices on how healthcare 
resources are allocated and acknowledge the opportunity costs associated with any investment. The 
attractiveness of a ‘common currency’ that allows decision makers to compare interventions on equal terms 
is obvious and explains why cost utility analysis, reporting outcomes in the form of a cost per QALY, rapidly 
expanded over recent decades. As a theoretical framework, cost utility analysis allows decision makers to 
prioritise investments based on their return on investment, using societal health outcomes as the objective 
function. Unfortunately, in practice, this theoretical framework is a poor reflection of how the majority of 
healthcare investment decisions are made, particularly at a sub-national, provider level. The qualitative 
research presented in Chapter 3 illustrates that many of the concepts and outcomes of formal economic 
evaluations are alien to front-line healthcare decision makers that operate in a much more pragmatic fashion. 
A more recent qualitative study of the use of health economics in local authority decisions on public health 
investments (Frew 2020) suggests that many of the issues identified have not improved over time. Whilst 
there may be a greater familiarity with health economic concepts their applicability to real-world decision 
making remains limited. The majority of healthcare resources are essentially ‘sunk’ – for example, staff and 
infrastructure costs - with limited opportunities for wholesale re-allocation in the short-term. The rational cost 
utility framework assumes that innovative, cost effective interventions are funded through disinvestment in 
less effective services to release the necessary funds. To do so assumes, firstly, that the cost effectiveness of 
all current interventions is known allowing less effective interventions to be identified and secondly, that 
disinvestment in existing services is feasible. This is particularly relevant to public health interventions where 
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the evidence on clinical and cost effectiveness may be limited and where it may be politically challenging to 
remove a service/intervention even where there is uncertainy over the value-for-money.  
As a result of these issues, many health service investments are made using more pragmatic approaches, often 
involving marginal re-allocations of resources to permit access to innovative health interventions. Whilst some 
degree of resource allocation is required to release resources, this is often achieved through a ‘salami-slicing’ 
approach, where resources may be taken from multiple services to support a new intervention, rather than 
wholesale removal of a less cost effective intervention. Whilst this approach falls short of the robust principles 
of cost utility analysis and extra-welfarism discussed in Chapter 2, it is still incumbent on decision makers to 
attempt to adopt an informed approach to resource allocation that considers the costs and benefits of an 
intervention prior to investment.   
The applied economic evaluations considered herein are intended to illustrate how health economics can be 
presented in a way that is both informative but also pragmatic for decision makers. The evaluations consider 
a range of public health interventions, including targeted, individual level interventions to promote 
breastfeeding, weight management and physical activity, as well as population level interventions to the 
environment. These case studies address the first objective and highlight some of the challenges inherent in 
the economic evaluation of public health interventions which are summarised below.    
1. A paucity of robust data on the effectiveness of public health interventions. The difficulties of 
conducting high-quality studies of the effectiveness of public health interventions, that illustrate 
attribution of the effect to the intervention, undermine the ability to conduct cost effectiveness 
analysis. As a result, many of the studies presented herein adopt gross assumptions to estimate cost 
effectiveness. Examples included in the evaluations herein include assumptions that improvements in 
physical activity levels are sustained over a lifetime based on limited follow-up information or weight 
loss is sustained beyond the duration of an intervention. Multiple scenarios are often used to address 
uncertainty. Whilst this may help to improve the transparency of the findings it does add significant 
complexity to interpreting the results, as is the case in the studies of breastfeeding and weight loss 
programmes presented herein.   
2. The reliance on a composite outcome, such as the incremental cost per QALY, can be misleading.  
Guidelines for economic evaluation have promoted the use of cost utility analysis and the use of the 
incremental cost per QALY as the preferred endpoint. Several of the studies reported herein suggest 
that the point estimate of the cost per QALY is dominant or within acceptable levels and the 
intervention should therefore be considered cost effective. However, disaggregating this composite 
outcome illustrates that in some instances the lifetime benefit is small or even negligible. For example, 
the evaluation of exercise referral programmes generated a lifetime QALY gain of 0.008, which is 
approximately 3 days of incremental full health per year over an entire lifetime. Any small change in 
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the outcome will have a notable effect on the resulting cost effectiveness and may even change an 
intervention from being considered cost effective to cost ineffective. This begs the question of 
whether a model containing incremental differences between the control and intervention arm to 
three decimal places, coupled with significant assumptions about the duration of effect, should be 
considered to be spuriously accurate and a suitable basis for investment decisions.   
3. Economic evaluations of public health interventions need to be accessible to multiple stakeholders 
with different perspectives.  In some of the instances presented herein, health is the primary outcome, 
as in the case of interventions to promote weight management, and a cost utility framework that 
assumes a health maximisation objective may be appropriate. However, in other cases, such as the 
activity trails to promote physical activity, impacts may be more widespread and the decision to invest 
will typically involve multiple agencies, including health, social care, local authorities and even private 
sector businesses. Presenting the results in a tightly defined ‘health’ framework may be confusing for 
decision makers who are unfamiliar with the concept of the QALY and concerned that it does not take 
into account the full range of costs and benefits associated with an intervention.   
  
The case studies compare and contrast alternative approaches to economic evaluation of public health 
programmes and some of the challenges associated with cost utility analysis are discussed at length. Cost 
benefit analysis is widely used in non-health sectors, including local planning and environmental management 
and is recognised in guidelines for economic evaluation of non-health investments (HM Treasury n.d.). There 
is something intrinsically appealing about a simple ratio that states for every £1 spent, £11 of benefits will 
accrue to society. However, this still faces the same issues that relate to cost utility analysis described above, 
namely that the ratio may hide small changes in costs and/or outcomes and may be susceptible to uncertainty.  
When presented as an aggregated cost benefit ratio it also fails to provide clarity on when, where and to whom 
costs and benefits accrue which may be problematic for public health interventions which have inter-sectoral 
approaches.    
The cost consequence analyses presented herein are believed to provide a more granular view of both costs 
and consequences and, crucially, allow decision makers to explore where these might be accrued.  
Furthermore, CCA might also allow for a wider range of costs and benefits to be considered even where these 
cannot be quantified. In the case of exercise referral programmes, it was possible to provide an indication of 
which direction outcomes would be expected to move in for a range of conditions which could not be captured 
in the cost utility analysis.  
Of course, CCA is not without it’s limitations; whilst results can be presented in a granular and disaggregated 
way which is likely to be more accessible, it requires decision makers to interpret the relative importance of 
outcomes without a common denominator, such as the QALY. Using the case studies presented herein, 
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interventions to promote increased breastfeeding and environmental interventions to promote physical 
activity were both found to offer significant benefits which may outweigh the costs of these interventions.  
However, without reporting these in a common currency, decision makers need to make subjective decisions 
on their relative value to determine how resources can be allocated. Put bluntly, is a targeted reduction in 
childhood morbidity more beneficial than an increase in population level physical activity? Whilst this may 
make justification of decisions more challenging, it is actually quite representative of how decisions are made 
in daily practice, and reflects some of the comments on economic methods presented in the chapter 3 as well 
as more recently literature (Frew 2020) which highlight that robust, quantitative methods are infrequently 
used in frontline healthcare decisions.   
Whilst health economists have developed increasingly sophisticated methods to evaluate healthcare 
interventions, there has been relatively little discussion of the contribution of qualitative methods which may 
be particularly pertinent to complex interventions, including public health interventions (Coast 2017). Several 
of the case studies reported herein highlight the challenges of quantifying the impact of public health 
interventions which could be informed by qualitative methods. Qualitative methods offer the potential to 
inform decisions on a number of levels, from societal preferences for the distribution of health effects, 
understanding trade-offs between health and other societal effects and providing further insights into how 
individuals perceive the benefits of health interventions. Indeed, there remain some significant macro-level 
considerations about the degree to which behaviour change and public health should be state initiated or the 
responsibility of the individual which could be informed by qualitative methods. Health economists are 
encouraged to consider not only their choice of quantitative method but also the potential role of qualitative 
methods in informing decisions.   
 
8.2. The author’s learning journey 
Over the course of the case studies, the author has illustrated continuous learning and a desire to apply 
methods that adequately address the decision problem and provide clarity for decision makers. The author 
selected studies for inclusion in this thesis on the basis that they provide a coherent illustration of learning 
from experience and adapting subsequent methods to improve the quality and accessibility of the findings.  
The first study selected for inclusion, reported in Chapter 3, is included as a foundational study that provided 
insights into how health economics is perceived in practice and has influenced all subsequent studies 
conducted by the author. The need to make economic evaluations to be ‘customer-centric’ and reflect the 
needs of decision makers runs throughout the case studies presented and continues to be a central tenet to 
the author’s research.   
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Early evaluations of the Counterweight programme (Chapter 4) and environmental interventions to promote 
physical activity (Chapter 5) sought to apply cost utility analysis, in line with prevailing methodological 
guidelines. However, it soon became apparent that there were limitations to this approach which lead to 
attempts to estimate short-term, more tangible impacts to illustrate the short-term return on investment. 
These narrower, short-term perspectives were considered to be in line with the typical time-horizons adopted 
in local authority decision making.   
The further analyses of breastfeeding interventions and exercise referral illustrate further development of the 
methods applied, through the use of cost consequence analysis as a means of providing a more easily 
accessible format for the outputs. This was particularly important in the case of the evaluation of 
breastfeeding interventions, as the sponsor (UNICEF UK) had a clear objective to promote policy level debate 
and engage the wider public. The ability to report outputs in a disaggregated way, in easily understood natural 
units, was critical to achieving this objective.   
The figure below provides an illustration of how the author has developed their methods over time.  
 
 
Figure 8.1: Methodolgical development over time illustrated by the studies presented in the thesis.  
The following section is intended to address the third objective of the thesis by providing some 
recommendations for future economic evaluations of public health interventions.   
 
8.3 Recommendations for future research  
Reflecting on the initial research presented in chapter 3, it is important that the health economics community 
becomes more ‘customer-focussed’ if it wants to influence decision making rather than pursuing the academic 
67 
 
dogma of cost utility analysis which assumes that all investments are designed to maximise health gains. To 
do so, it is important that the needs of decision makers are reflected in both the methods and the presentation 
of results. There are a number of review articles and commentaries which have considered the shortcomings 
of cost utility analysis as a means of evaluating public health interventions (Tudor-Edwards et al 2013) 
(Weatherly et al 2009). These have largely been consensual about the nature of the challenges and have 
repeatedly suggested that alternative methods should be considered. However, there has been relatively little 
movement in guidelines for economic evaluation to reflect these concerns. The NICE guidelines comment on 
the use of alternative methods whilst the CDC guidance has gone further to emphasise the need for a logic 
framework and discuss the use of CBA techniques. Whilst cost benefit analysis allows for a holistic assessment 
and is widely used in other disciplines there are well documented challenges to valuing benefits in monetary 
terms in a consistent fashion (McIntosh et al 2019). Others have concluded that CCA should play a greater role 
in public health evaluations (Brousselle et al 2016)(Lung et al 2017) on the basis that it provides a more 
granular perspective and in doing so can meet the needs of multiple decision makers. It is important for health 
economists to remember the foundations of economic evaluation and the application to healthcare. Many of 
the earliest texts on this subject were grounded in cost benefit analysis techniques which were prevalent in 
non-healthcare sector decision making processes (Hutton 1992). Over time, the methods adopted in health 
economics seem to have become more insular, paying less attention to the broader fields of economic 
evaluation and their applicability to healthcare.    
Based on the lessons learned from the studies presented herein, I would like to offer an alternative framework 
for economic evaluations of public health interventions which seeks to address methodological weaknesses 
and improve accessibility for decision makers. The principal tenet is that a disaggregated cost consequence 
analysis should be the primary, preferred method for evaluation on the basis that:   
a. It is a more transparent means of presenting costs and outcomes in a disaggregated fashion than an 
incremental cost effectiveness ratio and, in doing so, allows decision makers to see the absolute 
changes in costs and outcomes and the degree to which these are meaningful;   
b. It has the potential to consider health and non-health outcomes and does not start from a pre-defined 
view that health maximisation is the primary objective of the intervention;   
c. It is accessible to a wider range of decision makers from multiple sectors and allows them to determine 
impacts relevant to them.   
A cost consequence should be the preferred primary method. In the case of interventions where the primary 
outcome is a health benefit and there are relatively few non-health related outcomes, then a cost utility 
analysis could be presented as a secondary analysis. However, outcomes should first be presented in a 
disaggregated fashion in natural units. In cases where there are significant non-health benefits and/or the cost 
is expected to be covered by non-health sector decision makers then cost utility is not recommended as it 
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assumes the objective is QALY maximisation. In these instances, CBA may be considered as a secondary 
method to quantify the impacts where this is feasible. However, in many cases there may be some significant 
challenges to valuing all costs and benefits in monetary terms which may preclude a robust CBA.    
The flowchart below attempts to provide guidance for economists tasked with evaluating public health 
interventions.    
  
  
Figure 8.2: Flowchart to guide future economic evaluation for public health interventions  
  
It is hoped that the discussion of methods in this thesis and the concluding recommendations provide some 
pragmatic guidance for future evaluations of public health and also contribute to the future research agenda 
on the appropriateness of economic methods and the accessibility of outcomes to decision makers.    
 
8.4 Impact/originality of the thesis  
The case studies presented herein represent a significant body of applied research of public health 
interventions. In the majority of cases, these studies were commissioned to inform the development of 
national guidelines (notably from NICE) or to inform policy decisions on the coverage and adoption of public 
health interventions (e.g. breastfeeding and exercise referral schemes). In some cases, the research had a 
direct impact on national guidelines, for example in the case of the evaluation of interventions to promote 
physical activity. In other cases, the research contributed to an advancement in knowledge around a particular 
issue with the intention of promoting further uptake, such as the evaluation of breastfeeding. One notable 
exception is the evaluation of exercise referral schemes which found the evidence to be equivocal and 
questioned the case for continued investment. This is unusual in the field of public health where the majority 
of the evidence reviewed is largely positive about the potential effectiveness and cost effectiveness. It would 
be interesting to conduct further research to explore publication bias in this field and whether a degree of 
paternalism (prevention is better than cure) leads to fewer studies with negative findings.  
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It is hoped that some of the evaluations presented above may have influenced both guidelines and other 
researchers. The methods guidance for public health guidelines issued by NICE does reference alternative 
methods for economic evaluation which may have been influenced by the research presented in chapter 4 as 
well as other studies conducted by the author that were commissioned to support NICE guidelines on smoking 
cessation and physical activity in children (not included in this thesis). Furthermore, some of the studies have 
been extensively referenced by other researchers, notably the research on breastfeeding (~75 citations) and 
exercise referral schemes (>100 citations)1.     
The critique of economic evaluation methods applied to public health interventions concurs with the findings 
of previous reviews which have noted the shortcomings of cost utility analysis and cost benefit analysis and 
promoted more pragmatic solutions, such as cost consequence analysis. However, the original element of the 
thesis is the use of applied examples to illustrate how these shortcomings manifest themselves in practice.  
The inability to accurately estimate causality and attribution to public health interventions was evidence in 
the population level evaluations. Similarly, several of the case studies illustrate that reliance on a composite 
outcome, such as the QALY, may fail to fully capture the benefits of an intervention and simultaneously narrow 
the applicability of the findings to select stakeholders. The attempts to apply cost consequence analysis are 
intended to show that this approach can result in a holistic and transparent reporting of the costs and 
outcomes of public health interventions and in doing so significantly increase the relevance to a wider range 
of stakeholders.    
As with any research endeavour it is important to acknowledge some of the weaknesses of this thesis. The 
thesis is based on a series of applied research projects commissioned by multiple organisations across multiple 
interventions. Whilst there are thematic trends across the studies, it was not been possible to fully explore all 
the methodological issues in each applied case study due to limits on the research funding and the 
requirement to complete research to a schedule, for example, to input to guideline publication. Furthermore, 
the research spans over a decade of publications. This was necessary due to the long-term nature of some of 
the studies and the time-lags for publication.  I should also want to acknowledge that the publications include 
multiple co-contributors. Whilst the author was the lead or co-lead investigator in all these research 
programmes it is important to acknowledge that the majority of the studies were undertaken  by a research 
team with authorship reflecting this. In some instances, lead authorship was granted to junior researchers to 
support their academic development.  
Finally, it was beyond the scope of this research to conduct a comprehensive, systematic review of the 
economic evaluations of public health interventions which would have provided a more holistic view of the 
prevailing methods of economic evaluation. An additional area for further research would be qualitative 
 
1 Citations derived from Researchgate August 2020  
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studies of the use of economic evaluation by decision makers. The flurry of papers produced on this topic in 
the mid-1990s (including the paper referenced in Chapter 3) has waned over time and there is an urgent need 
for the health economics community to reflect on how its methods and outputs are being used if it is to remain 
relevant. Further research relating specifically to public health decision making would be of particular interest 
given the complexity of the decision-making processes and the multiplicity of stakeholders involved.   
Despite these shortcomings, it is hoped that the thesis provides original insights into the challenges of 
economic evaluation of public health through applied examples and provides guidance on methods that may 
help to improve the impact and accessibility of future economic evaluations.    
 
8.5 Conclusions  
The evaluation of public health interventions is inherently more complex than the evaluation of other 
healthcare interventions such as medical technologies or pharmaceuticals. The challenges inherent in 
generating high quality data to illustrate the attributable effect of public health interventions are very real and 
the multi-sectoral nature of many such interventions creates further complexity in the reporting of costs and 
outcomes. For these reasons, it is suggested that the most widely used methods of economic evaluation in 
healthcare, particularly cost utility analysis, are inappropriate. Cost consequence analysis provides a more 
granular approach to reporting costs and outcomes, allowing multiple decision makers to identify where costs 
and benefits are accrued. Where appropriate, these outcomes can be further extrapolated into a cost utility 
ratio or cost benefit ratio, but outcomes should always be reported in a disaggregated fashion prior to being 
aggregated into a composite measure. Health economists working in the field of public health are encouraged 
to prioritise generating evidence that meets the needs of decision makers, rather than adhering dogmatically 
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